Exelixis share price today
Exelixis, Inc. · EXEL · Healthcare · Biotechnology · price as of the 4 November 2026 close, updated every trading day · results updated weekly · All US stock lists
Exelixis share price: $72.75 at the close on 4 November 2026, +78.3% in a year.
Exelixis, Inc. is reporting record margins.
Biggest thing to watch: margins are the best this company has ever reported. Every ratio looks better at a record, so the story depends on margins staying high.
The price has been rising for 32 weeks, and the P/E is higher than 54% of its own last 4.6 years. Over the last four quarters, results have been improving, with profit +14.7% on a year earlier, and 127% of the last 3 years' profit came in as cash. What will decide it: the next one or two quarters of results.
What is the Exelixis share price today?
Exelixis, Inc.'s share price was $72.75 at the close on 4 November 2026. It has been rising for 32 weeks. That is 41.8% above its average price over the last 200 trading days. In the last 52 weeks it traded between $41 and $73, and at that close it was at the high of that range.
A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Exelixis, Inc. is in stage 2. The phase helps read everything below.
Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 12 weeks in a row.
1Y
Nov 2026: $72.75, 41.8% above its 200-day average. The price has been rising for 32 weeks.
- Price $72.75
- 50-day avg $60.38
- 200-day avg $51.32
| Week | Price | 50-day avg | 200-day avg |
|---|---|---|---|
| 31 Oct 2025 | $38.67 | $38.83 | $38.85 |
| 7 Nov 2025 | $40.81 | $38.97 | $38.95 |
| 14 Nov 2025 | $41.65 | $39.47 | $39.20 |
| 21 Nov 2025 | $42.51 | $39.86 | $39.42 |
| 28 Nov 2025 | $44.17 | $40.16 | $39.63 |
| 5 Dec 2025 | $44.36 | $40.61 | $39.86 |
| 12 Dec 2025 | $40.88 | $40.69 | $39.96 |
| 19 Dec 2025 | $44.30 | $40.98 | $40.06 |
| 26 Dec 2025 | $46.24 | $41.57 | $40.23 |
| 2 Jan 2026 | $43.58 | $42.13 | $40.38 |
| 9 Jan 2026 | $44.04 | $42.68 | $40.55 |
| 16 Jan 2026 | $43.96 | $43.27 | $40.74 |
| 23 Jan 2026 | $44.27 | $43.55 | $40.91 |
| 30 Jan 2026 | $41.36 | $43.57 | $41.11 |
| 6 Feb 2026 | $43.90 | $43.63 | $41.27 |
| 13 Feb 2026 | $43.92 | $43.59 | $41.41 |
| 20 Feb 2026 | $43.63 | $43.62 | $41.51 |
| 27 Feb 2026 | $44.06 | $43.93 | $41.70 |
| 6 Mar 2026 | $41.55 | $43.72 | $41.64 |
| 13 Mar 2026 | $41.24 | $43.30 | $41.60 |
| 20 Mar 2026 | $41.27 | $43.04 | $41.57 |
| 27 Mar 2026 | $41.53 | $42.80 | $41.55 |
| 2 Apr 2026 | $43.88 | $42.70 | $41.58 |
| 10 Apr 2026 | $44.27 | $42.76 | $41.63 |
| 17 Apr 2026 | $44.89 | $43.02 | $41.66 |
| 24 Apr 2026 | $44.94 | $43.24 | $41.69 |
| 1 May 2026 | $43.68 | $43.30 | $41.68 |
| 8 May 2026 | $48.16 | $43.50 | $41.72 |
| 15 May 2026 | $50.13 | $44.36 | $41.94 |
| 22 May 2026 | $50.15 | $45.16 | $42.25 |
| 29 May 2026 | $50.48 | $45.89 | $42.51 |
| 5 Jun 2026 | $52.70 | $46.83 | $42.83 |
| 12 Jun 2026 | $53.13 | $47.86 | $43.20 |
| 18 Jun 2026 | $51.91 | $48.53 | $43.49 |
| 26 Jun 2026 | $54.77 | $49.30 | $43.86 |
| 2 Jul 2026 | $55.85 | $50.10 | $44.18 |
| 10 Jul 2026 | $56.50 | $51.19 | $44.60 |
| 17 Jul 2026 | $55.92 | $52.34 | $45.01 |
| 24 Jul 2026 | $55.37 | $53.05 | $45.37 |
| 31 Jul 2026 | $53.03 | $53.57 | $45.79 |
| 7 Aug 2026 | $54.07 | $54.05 | $46.20 |
| 14 Aug 2026 | $51.24 | $54.14 | $46.53 |
| 21 Aug 2026 | $54.08 | $54.24 | $46.90 |
| 28 Aug 2026 | $54.45 | $54.50 | $47.28 |
| 4 Sep 2026 | $59.01 | $55.05 | $47.65 |
| 11 Sep 2026 | $56.12 | $55.29 | $47.95 |
| 18 Sep 2026 | $58.36 | $55.39 | $48.30 |
| 25 Sep 2026 | $58.16 | $55.56 | $48.65 |
| 2 Oct 2026 | $58.39 | $55.83 | $49.08 |
| 9 Oct 2026 | $59.86 | $56.14 | $49.47 |
| 16 Oct 2026 | $62.23 | $56.79 | $49.85 |
| 23 Oct 2026 | $64.53 | $58.04 | $50.36 |
| 30 Oct 2026 | $69.39 | $59.39 | $50.91 |
| 4 Nov 2026 | $72.75 | $60.38 | $51.32 |
3Y
Nov 2026: $72.75, 41.8% above its 200-day average. The price has been rising for 32 weeks.
- Price $72.75
- 50-day avg $60.38
- 200-day avg $51.32
| Week | Price | 50-day avg | 200-day avg |
|---|---|---|---|
| 3 Nov 2023 | $21.00 | $21.55 | $19.60 |
| 10 Nov 2023 | $21.00 | $21.41 | $19.69 |
| 17 Nov 2023 | $21.13 | $21.30 | $19.78 |
| 24 Nov 2023 | $21.68 | $21.24 | $19.86 |
| 1 Dec 2023 | $21.94 | $21.24 | $19.95 |
| 8 Dec 2023 | $22.00 | $21.25 | $20.07 |
| 15 Dec 2023 | $23.41 | $21.35 | $20.21 |
| 22 Dec 2023 | $23.94 | $21.55 | $20.39 |
| 29 Dec 2023 | $23.99 | $21.75 | $20.52 |
| 5 Jan 2024 | $23.24 | $22.03 | $20.63 |
| 12 Jan 2024 | $22.70 | $22.26 | $20.74 |
| 19 Jan 2024 | $22.48 | $22.40 | $20.81 |
| 26 Jan 2024 | $22.12 | $22.54 | $20.86 |
| 2 Feb 2024 | $21.49 | $22.60 | $20.92 |
| 9 Feb 2024 | $20.22 | $22.53 | $20.96 |
| 16 Feb 2024 | $20.48 | $22.39 | $21.01 |
| 23 Feb 2024 | $21.53 | $22.30 | $21.04 |
| 1 Mar 2024 | $22.24 | $22.17 | $21.11 |
| 8 Mar 2024 | $22.21 | $22.03 | $21.18 |
| 15 Mar 2024 | $22.98 | $21.91 | $21.27 |
| 22 Mar 2024 | $23.78 | $21.96 | $21.37 |
| 28 Mar 2024 | $23.73 | $22.05 | $21.46 |
| 5 Apr 2024 | $23.14 | $22.16 | $21.58 |
| 12 Apr 2024 | $22.81 | $22.28 | $21.67 |
| 19 Apr 2024 | $22.52 | $22.42 | $21.76 |
| 26 Apr 2024 | $23.70 | $22.73 | $21.87 |
| 3 May 2024 | $21.90 | $22.93 | $21.95 |
| 10 May 2024 | $21.37 | $22.93 | $22.00 |
| 17 May 2024 | $20.91 | $22.81 | $22.03 |
| 24 May 2024 | $20.57 | $22.63 | $22.04 |
| 31 May 2024 | $21.69 | $22.43 | $22.02 |
| 7 Jun 2024 | $21.88 | $22.25 | $22.04 |
| 14 Jun 2024 | $21.74 | $22.08 | $22.04 |
| 21 Jun 2024 | $22.20 | $21.95 | $22.03 |
| 28 Jun 2024 | $22.47 | $21.91 | $22.03 |
| 5 Jul 2024 | $22.10 | $21.86 | $22.04 |
| 12 Jul 2024 | $22.40 | $21.72 | $22.06 |
| 19 Jul 2024 | $22.60 | $21.78 | $22.07 |
| 26 Jul 2024 | $23.39 | $21.92 | $22.09 |
| 2 Aug 2024 | $24.17 | $22.18 | $22.14 |
| 9 Aug 2024 | $26.97 | $22.67 | $22.26 |
| 16 Aug 2024 | $26.35 | $23.16 | $22.42 |
| 23 Aug 2024 | $25.88 | $23.58 | $22.56 |
| 30 Aug 2024 | $26.03 | $23.99 | $22.68 |
| 6 Sep 2024 | $25.15 | $24.25 | $22.77 |
| 13 Sep 2024 | $26.46 | $24.65 | $22.89 |
| 20 Sep 2024 | $26.42 | $25.13 | $23.02 |
| 27 Sep 2024 | $25.96 | $25.49 | $23.13 |
| 4 Oct 2024 | $26.66 | $25.87 | $23.20 |
| 11 Oct 2024 | $26.23 | $26.10 | $23.26 |
| 18 Oct 2024 | $28.90 | $26.44 | $23.37 |
| 25 Oct 2024 | $27.87 | $26.61 | $23.50 |
| 1 Nov 2024 | $34.12 | $27.12 | $23.72 |
| 8 Nov 2024 | $36.25 | $28.07 | $24.04 |
| 15 Nov 2024 | $34.45 | $29.04 | $24.38 |
| 22 Nov 2024 | $35.61 | $29.90 | $24.73 |
| 29 Nov 2024 | $36.46 | $30.63 | $25.05 |
| 6 Dec 2024 | $35.82 | $31.57 | $25.42 |
| 13 Dec 2024 | $35.03 | $32.47 | $25.76 |
| 20 Dec 2024 | $33.29 | $33.31 | $26.06 |
| 27 Dec 2024 | $33.81 | $33.81 | $26.28 |
| 3 Jan 2025 | $33.97 | $34.20 | $26.49 |
| 10 Jan 2025 | $36.02 | $34.70 | $26.71 |
| 17 Jan 2025 | $36.20 | $35.06 | $27.02 |
| 24 Jan 2025 | $32.38 | $34.93 | $27.23 |
| 31 Jan 2025 | $33.15 | $34.69 | $27.48 |
| 7 Feb 2025 | $33.48 | $34.54 | $27.74 |
| 14 Feb 2025 | $35.00 | $34.30 | $28.00 |
| 21 Feb 2025 | $36.85 | $34.26 | $28.25 |
| 28 Feb 2025 | $38.69 | $34.50 | $28.65 |
| 7 Mar 2025 | $38.58 | $34.92 | $29.08 |
| 14 Mar 2025 | $36.65 | $35.27 | $29.50 |
| 21 Mar 2025 | $36.96 | $35.59 | $29.89 |
| 28 Mar 2025 | $36.70 | $35.74 | $30.27 |
| 4 Apr 2025 | $34.57 | $35.85 | $30.63 |
| 11 Apr 2025 | $35.31 | $36.06 | $30.95 |
| 17 Apr 2025 | $36.19 | $36.30 | $31.23 |
| 25 Apr 2025 | $37.43 | $36.64 | $31.59 |
| 2 May 2025 | $39.60 | $37.06 | $32.01 |
| 9 May 2025 | $36.17 | $37.06 | $32.37 |
| 16 May 2025 | $45.40 | $37.41 | $32.85 |
| 23 May 2025 | $42.39 | $38.00 | $33.35 |
| 30 May 2025 | $43.04 | $38.48 | $33.66 |
| 6 Jun 2025 | $43.03 | $39.01 | $34.07 |
| 13 Jun 2025 | $41.59 | $39.54 | $34.47 |
| 20 Jun 2025 | $40.37 | $40.02 | $34.77 |
| 27 Jun 2025 | $43.67 | $40.86 | $35.23 |
| 3 Jul 2025 | $46.15 | $41.54 | $35.59 |
| 11 Jul 2025 | $44.86 | $42.20 | $36.03 |
| 18 Jul 2025 | $44.47 | $42.79 | $36.49 |
| 25 Jul 2025 | $45.60 | $43.61 | $36.95 |
| 1 Aug 2025 | $37.26 | $42.94 | $37.27 |
| 8 Aug 2025 | $37.72 | $42.39 | $37.49 |
| 15 Aug 2025 | $38.31 | $41.94 | $37.74 |
| 22 Aug 2025 | $38.63 | $41.50 | $37.90 |
| 29 Aug 2025 | $37.42 | $41.16 | $37.97 |
| 5 Sep 2025 | $37.88 | $40.69 | $38.01 |
| 12 Sep 2025 | $39.15 | $40.15 | $38.10 |
| 19 Sep 2025 | $40.10 | $39.67 | $38.19 |
| 26 Sep 2025 | $39.04 | $39.11 | $38.28 |
| 3 Oct 2025 | $40.09 | $38.73 | $38.42 |
| 10 Oct 2025 | $38.15 | $38.63 | $38.54 |
| 17 Oct 2025 | $39.25 | $38.83 | $38.68 |
| 24 Oct 2025 | $38.72 | $38.70 | $38.75 |
| 31 Oct 2025 | $38.67 | $38.83 | $38.85 |
| 7 Nov 2025 | $40.81 | $38.97 | $38.95 |
| 14 Nov 2025 | $41.65 | $39.47 | $39.20 |
| 21 Nov 2025 | $42.51 | $39.86 | $39.42 |
| 28 Nov 2025 | $44.17 | $40.16 | $39.63 |
| 5 Dec 2025 | $44.36 | $40.61 | $39.86 |
| 12 Dec 2025 | $40.88 | $40.69 | $39.96 |
| 19 Dec 2025 | $44.30 | $40.98 | $40.06 |
| 26 Dec 2025 | $46.24 | $41.57 | $40.23 |
| 2 Jan 2026 | $43.58 | $42.13 | $40.38 |
| 9 Jan 2026 | $44.04 | $42.68 | $40.55 |
| 16 Jan 2026 | $43.96 | $43.27 | $40.74 |
| 23 Jan 2026 | $44.27 | $43.55 | $40.91 |
| 30 Jan 2026 | $41.36 | $43.57 | $41.11 |
| 6 Feb 2026 | $43.90 | $43.63 | $41.27 |
| 13 Feb 2026 | $43.92 | $43.59 | $41.41 |
| 20 Feb 2026 | $43.63 | $43.62 | $41.51 |
| 27 Feb 2026 | $44.06 | $43.93 | $41.70 |
| 6 Mar 2026 | $41.55 | $43.72 | $41.64 |
| 13 Mar 2026 | $41.24 | $43.30 | $41.60 |
| 20 Mar 2026 | $41.27 | $43.04 | $41.57 |
| 27 Mar 2026 | $41.53 | $42.80 | $41.55 |
| 2 Apr 2026 | $43.88 | $42.70 | $41.58 |
| 10 Apr 2026 | $44.27 | $42.76 | $41.63 |
| 17 Apr 2026 | $44.89 | $43.02 | $41.66 |
| 24 Apr 2026 | $44.94 | $43.24 | $41.69 |
| 1 May 2026 | $43.68 | $43.30 | $41.68 |
| 8 May 2026 | $48.16 | $43.50 | $41.72 |
| 15 May 2026 | $50.13 | $44.36 | $41.94 |
| 22 May 2026 | $50.15 | $45.16 | $42.25 |
| 29 May 2026 | $50.48 | $45.89 | $42.51 |
| 5 Jun 2026 | $52.70 | $46.83 | $42.83 |
| 12 Jun 2026 | $53.13 | $47.86 | $43.20 |
| 18 Jun 2026 | $51.91 | $48.53 | $43.49 |
| 26 Jun 2026 | $54.77 | $49.30 | $43.86 |
| 2 Jul 2026 | $55.85 | $50.10 | $44.18 |
| 10 Jul 2026 | $56.50 | $51.19 | $44.60 |
| 17 Jul 2026 | $55.92 | $52.34 | $45.01 |
| 24 Jul 2026 | $55.37 | $53.05 | $45.37 |
| 31 Jul 2026 | $53.03 | $53.57 | $45.79 |
| 7 Aug 2026 | $54.07 | $54.05 | $46.20 |
| 14 Aug 2026 | $51.24 | $54.14 | $46.53 |
| 21 Aug 2026 | $54.08 | $54.24 | $46.90 |
| 28 Aug 2026 | $54.45 | $54.50 | $47.28 |
| 4 Sep 2026 | $59.01 | $55.05 | $47.65 |
| 11 Sep 2026 | $56.12 | $55.29 | $47.95 |
| 18 Sep 2026 | $58.36 | $55.39 | $48.30 |
| 25 Sep 2026 | $58.16 | $55.56 | $48.65 |
| 2 Oct 2026 | $58.39 | $55.83 | $49.08 |
| 9 Oct 2026 | $59.86 | $56.14 | $49.47 |
| 16 Oct 2026 | $62.23 | $56.79 | $49.85 |
| 23 Oct 2026 | $64.53 | $58.04 | $50.36 |
| 30 Oct 2026 | $69.39 | $59.39 | $50.91 |
| 4 Nov 2026 | $72.75 | $60.38 | $51.32 |
5Y
Nov 2026: $72.75, 41.8% above its 200-day average. The price has been rising for 32 weeks.
- Price $72.75
- 50-day avg $60.38
- 200-day avg $51.32
| Week | Price | 50-day avg | 200-day avg |
|---|---|---|---|
| 29 Oct 2021 | $21.51 | $20.55 | $21.40 |
| 12 Nov 2021 | $18.10 | $20.57 | $21.23 |
| 26 Nov 2021 | $17.06 | $20.14 | $21.00 |
| 10 Dec 2021 | $16.65 | $19.34 | $20.72 |
| 23 Dec 2021 | $19.28 | $18.78 | $20.54 |
| 7 Jan 2022 | $18.74 | $18.20 | $20.32 |
| 21 Jan 2022 | $17.32 | $17.75 | $20.09 |
| 4 Feb 2022 | $18.79 | $17.81 | $19.80 |
| 18 Feb 2022 | $19.56 | $18.28 | $19.53 |
| 4 Mar 2022 | $20.70 | $18.77 | $19.33 |
| 18 Mar 2022 | $21.39 | $19.17 | $19.22 |
| 1 Apr 2022 | $22.89 | $19.98 | $19.19 |
| 14 Apr 2022 | $23.09 | $20.87 | $19.26 |
| 29 Apr 2022 | $22.34 | $21.62 | $19.50 |
| 13 May 2022 | $20.08 | $21.82 | $19.71 |
| 27 May 2022 | $18.40 | $21.38 | $19.78 |
| 10 Jun 2022 | $18.14 | $20.86 | $19.79 |
| 24 Jun 2022 | $22.22 | $20.20 | $19.77 |
| 8 Jul 2022 | $22.01 | $19.99 | $19.83 |
| 22 Jul 2022 | $20.86 | $19.88 | $19.86 |
| 5 Aug 2022 | $21.52 | $20.31 | $19.85 |
| 19 Aug 2022 | $19.33 | $20.53 | $19.76 |
| 2 Sep 2022 | $17.91 | $20.47 | $19.75 |
| 16 Sep 2022 | $17.15 | $19.74 | $19.76 |
| 30 Sep 2022 | $15.68 | $18.69 | $19.74 |
| 14 Oct 2022 | $15.65 | $17.60 | $19.59 |
| 28 Oct 2022 | $16.63 | $16.89 | $19.49 |
| 11 Nov 2022 | $16.80 | $16.50 | $19.44 |
| 25 Nov 2022 | $16.94 | $16.37 | $19.37 |
| 9 Dec 2022 | $15.77 | $16.44 | $19.25 |
| 23 Dec 2022 | $15.83 | $16.47 | $19.00 |
| 6 Jan 2023 | $17.27 | $16.46 | $18.81 |
| 20 Jan 2023 | $16.73 | $16.48 | $18.56 |
| 3 Feb 2023 | $17.55 | $16.62 | $18.29 |
| 17 Feb 2023 | $17.49 | $16.75 | $18.04 |
| 3 Mar 2023 | $17.15 | $16.98 | $17.89 |
| 17 Mar 2023 | $17.55 | $17.20 | $17.83 |
| 31 Mar 2023 | $19.41 | $17.60 | $17.83 |
| 14 Apr 2023 | $19.46 | $18.04 | $17.82 |
| 28 Apr 2023 | $18.30 | $18.29 | $17.69 |
| 12 May 2023 | $19.18 | $18.65 | $17.58 |
| 26 May 2023 | $19.13 | $19.14 | $17.50 |
| 9 Jun 2023 | $19.20 | $19.29 | $17.50 |
| 23 Jun 2023 | $19.86 | $19.21 | $17.55 |
| 7 Jul 2023 | $19.31 | $19.20 | $17.63 |
| 21 Jul 2023 | $19.69 | $19.30 | $17.78 |
| 4 Aug 2023 | $20.27 | $19.40 | $18.00 |
| 18 Aug 2023 | $21.10 | $19.76 | $18.23 |
| 1 Sep 2023 | $22.74 | $20.34 | $18.50 |
| 15 Sep 2023 | $21.81 | $20.86 | $18.74 |
| 29 Sep 2023 | $21.85 | $21.33 | $18.99 |
| 13 Oct 2023 | $21.36 | $21.70 | $19.29 |
| 27 Oct 2023 | $20.20 | $21.64 | $19.49 |
| 10 Nov 2023 | $21.00 | $21.41 | $19.69 |
| 24 Nov 2023 | $21.68 | $21.24 | $19.86 |
| 8 Dec 2023 | $22.00 | $21.25 | $20.07 |
| 22 Dec 2023 | $23.94 | $21.55 | $20.39 |
| 5 Jan 2024 | $23.24 | $22.03 | $20.63 |
| 19 Jan 2024 | $22.48 | $22.40 | $20.81 |
| 2 Feb 2024 | $21.49 | $22.60 | $20.92 |
| 16 Feb 2024 | $20.48 | $22.39 | $21.01 |
| 1 Mar 2024 | $22.24 | $22.17 | $21.11 |
| 15 Mar 2024 | $22.98 | $21.91 | $21.27 |
| 28 Mar 2024 | $23.73 | $22.05 | $21.46 |
| 12 Apr 2024 | $22.81 | $22.28 | $21.67 |
| 26 Apr 2024 | $23.70 | $22.73 | $21.87 |
| 10 May 2024 | $21.37 | $22.93 | $22.00 |
| 24 May 2024 | $20.57 | $22.63 | $22.04 |
| 7 Jun 2024 | $21.88 | $22.25 | $22.04 |
| 21 Jun 2024 | $22.20 | $21.95 | $22.03 |
| 5 Jul 2024 | $22.10 | $21.86 | $22.04 |
| 19 Jul 2024 | $22.60 | $21.78 | $22.07 |
| 2 Aug 2024 | $24.17 | $22.18 | $22.14 |
| 16 Aug 2024 | $26.35 | $23.16 | $22.42 |
| 30 Aug 2024 | $26.03 | $23.99 | $22.68 |
| 13 Sep 2024 | $26.46 | $24.65 | $22.89 |
| 27 Sep 2024 | $25.96 | $25.49 | $23.13 |
| 11 Oct 2024 | $26.23 | $26.10 | $23.26 |
| 25 Oct 2024 | $27.87 | $26.61 | $23.50 |
| 8 Nov 2024 | $36.25 | $28.07 | $24.04 |
| 22 Nov 2024 | $35.61 | $29.90 | $24.73 |
| 6 Dec 2024 | $35.82 | $31.57 | $25.42 |
| 20 Dec 2024 | $33.29 | $33.31 | $26.06 |
| 3 Jan 2025 | $33.97 | $34.20 | $26.49 |
| 17 Jan 2025 | $36.20 | $35.06 | $27.02 |
| 31 Jan 2025 | $33.15 | $34.69 | $27.48 |
| 14 Feb 2025 | $35.00 | $34.30 | $28.00 |
| 28 Feb 2025 | $38.69 | $34.50 | $28.65 |
| 14 Mar 2025 | $36.65 | $35.27 | $29.50 |
| 28 Mar 2025 | $36.70 | $35.74 | $30.27 |
| 11 Apr 2025 | $35.31 | $36.06 | $30.95 |
| 25 Apr 2025 | $37.43 | $36.64 | $31.59 |
| 9 May 2025 | $36.17 | $37.06 | $32.37 |
| 23 May 2025 | $42.39 | $38.00 | $33.35 |
| 6 Jun 2025 | $43.03 | $39.01 | $34.07 |
| 20 Jun 2025 | $40.37 | $40.02 | $34.77 |
| 3 Jul 2025 | $46.15 | $41.54 | $35.59 |
| 18 Jul 2025 | $44.47 | $42.79 | $36.49 |
| 1 Aug 2025 | $37.26 | $42.94 | $37.27 |
| 15 Aug 2025 | $38.31 | $41.94 | $37.74 |
| 29 Aug 2025 | $37.42 | $41.16 | $37.97 |
| 12 Sep 2025 | $39.15 | $40.15 | $38.10 |
| 26 Sep 2025 | $39.04 | $39.11 | $38.28 |
| 10 Oct 2025 | $38.15 | $38.63 | $38.54 |
| 24 Oct 2025 | $38.72 | $38.70 | $38.75 |
| 7 Nov 2025 | $40.81 | $38.97 | $38.95 |
| 21 Nov 2025 | $42.51 | $39.86 | $39.42 |
| 5 Dec 2025 | $44.36 | $40.61 | $39.86 |
| 19 Dec 2025 | $44.30 | $40.98 | $40.06 |
| 2 Jan 2026 | $43.58 | $42.13 | $40.38 |
| 16 Jan 2026 | $43.96 | $43.27 | $40.74 |
| 30 Jan 2026 | $41.36 | $43.57 | $41.11 |
| 13 Feb 2026 | $43.92 | $43.59 | $41.41 |
| 27 Feb 2026 | $44.06 | $43.93 | $41.70 |
| 13 Mar 2026 | $41.24 | $43.30 | $41.60 |
| 27 Mar 2026 | $41.53 | $42.80 | $41.55 |
| 10 Apr 2026 | $44.27 | $42.76 | $41.63 |
| 24 Apr 2026 | $44.94 | $43.24 | $41.69 |
| 8 May 2026 | $48.16 | $43.50 | $41.72 |
| 22 May 2026 | $50.15 | $45.16 | $42.25 |
| 5 Jun 2026 | $52.70 | $46.83 | $42.83 |
| 18 Jun 2026 | $51.91 | $48.53 | $43.49 |
| 2 Jul 2026 | $55.85 | $50.10 | $44.18 |
| 17 Jul 2026 | $55.92 | $52.34 | $45.01 |
| 31 Jul 2026 | $53.03 | $53.57 | $45.79 |
| 14 Aug 2026 | $51.24 | $54.14 | $46.53 |
| 28 Aug 2026 | $54.45 | $54.50 | $47.28 |
| 11 Sep 2026 | $56.12 | $55.29 | $47.95 |
| 25 Sep 2026 | $58.16 | $55.56 | $48.65 |
| 9 Oct 2026 | $59.86 | $56.14 | $49.47 |
| 23 Oct 2026 | $64.53 | $58.04 | $50.36 |
| 4 Nov 2026 | $72.75 | $60.38 | $51.32 |
10Y
Nov 2026: $72.75, 41.8% above its 200-day average. The price has been rising for 32 weeks.
- Price $72.75
- 50-day avg $60.38
- 200-day avg $51.32
| Week | Price | 50-day avg | 200-day avg |
|---|---|---|---|
| 28 Oct 2016 | $10.88 | $12.31 | – |
| 18 Nov 2016 | $16.96 | $13.09 | – |
| 9 Dec 2016 | $16.84 | $13.98 | – |
| 30 Dec 2016 | $14.91 | $14.99 | – |
| 20 Jan 2017 | $17.92 | $16.55 | – |
| 10 Feb 2017 | $22.08 | $17.54 | – |
| 3 Mar 2017 | $23.08 | $19.06 | – |
| 24 Mar 2017 | $20.91 | $20.78 | – |
| 13 Apr 2017 | $21.29 | $21.53 | – |
| 5 May 2017 | $21.69 | $21.60 | $16.35 |
| 26 May 2017 | $19.35 | $21.18 | $17.19 |
| 16 Jun 2017 | $19.26 | $20.65 | $17.77 |
| 7 Jul 2017 | $25.21 | $21.49 | $18.58 |
| 28 Jul 2017 | $27.63 | $22.96 | $19.58 |
| 18 Aug 2017 | $26.33 | $25.14 | $20.72 |
| 8 Sep 2017 | $25.97 | $26.71 | $21.62 |
| 29 Sep 2017 | $24.23 | $26.81 | $22.30 |
| 20 Oct 2017 | $27.17 | $26.53 | $23.09 |
| 10 Nov 2017 | $25.85 | $26.20 | $23.68 |
| 1 Dec 2017 | $28.12 | $25.85 | $24.07 |
| 22 Dec 2017 | $29.47 | $26.52 | $24.42 |
| 12 Jan 2018 | $30.38 | $27.56 | $25.02 |
| 2 Feb 2018 | $30.22 | $28.67 | $25.64 |
| 23 Feb 2018 | $29.51 | $29.31 | $26.13 |
| 16 Mar 2018 | $24.64 | $28.28 | $26.50 |
| 6 Apr 2018 | $21.09 | $26.29 | $26.70 |
| 27 Apr 2018 | $21.34 | $23.65 | $26.41 |
| 18 May 2018 | $21.58 | $21.87 | $25.97 |
| 8 Jun 2018 | $19.41 | $20.88 | $25.53 |
| 29 Jun 2018 | $21.52 | $20.56 | $24.98 |
| 20 Jul 2018 | $21.29 | $20.60 | $24.68 |
| 10 Aug 2018 | $20.40 | $20.74 | $24.28 |
| 31 Aug 2018 | $18.79 | $20.45 | $23.75 |
| 21 Sep 2018 | $16.76 | $19.41 | $23.12 |
| 12 Oct 2018 | $16.24 | $18.20 | $22.36 |
| 2 Nov 2018 | $17.41 | $16.91 | $21.26 |
| 23 Nov 2018 | $18.07 | $16.62 | $20.37 |
| 14 Dec 2018 | $21.03 | $17.56 | $19.82 |
| 4 Jan 2019 | $20.73 | $18.25 | $19.48 |
| 25 Jan 2019 | $23.27 | $20.34 | $19.54 |
| 15 Feb 2019 | $22.26 | $21.58 | $19.66 |
| 8 Mar 2019 | $23.04 | $22.19 | $19.75 |
| 29 Mar 2019 | $23.80 | $22.88 | $20.03 |
| 18 Apr 2019 | $20.90 | $23.07 | $20.26 |
| 10 May 2019 | $19.76 | $22.60 | $20.17 |
| 31 May 2019 | $19.59 | $21.51 | $20.09 |
| 21 Jun 2019 | $21.37 | $20.39 | $20.20 |
| 12 Jul 2019 | $20.98 | $20.35 | $20.47 |
| 2 Aug 2019 | $19.79 | $20.70 | $20.76 |
| 23 Aug 2019 | $20.05 | $20.92 | $21.15 |
| 13 Sep 2019 | $19.24 | $20.47 | $21.29 |
| 4 Oct 2019 | $17.04 | $19.70 | $21.14 |
| 25 Oct 2019 | $17.25 | $18.58 | $20.87 |
| 15 Nov 2019 | $16.51 | $17.33 | $20.35 |
| 6 Dec 2019 | $17.36 | $16.64 | $19.99 |
| 27 Dec 2019 | $18.13 | $16.92 | $19.64 |
| 17 Jan 2020 | $19.82 | $17.49 | $19.26 |
| 7 Feb 2020 | $19.02 | $18.11 | $18.95 |
| 28 Feb 2020 | $18.59 | $18.90 | $18.95 |
| 20 Mar 2020 | $15.15 | $18.56 | $18.74 |
| 9 Apr 2020 | $18.02 | $17.99 | $18.50 |
| 1 May 2020 | $24.10 | $19.14 | $18.64 |
| 22 May 2020 | $24.62 | $21.22 | $19.01 |
| 12 Jun 2020 | $22.39 | $23.27 | $19.20 |
| 2 Jul 2020 | $23.48 | $24.40 | $19.48 |
| 24 Jul 2020 | $24.59 | $23.88 | $19.94 |
| 14 Aug 2020 | $21.98 | $23.43 | $20.40 |
| 4 Sep 2020 | $20.67 | $23.08 | $20.84 |
| 25 Sep 2020 | $23.84 | $23.17 | $21.35 |
| 16 Oct 2020 | $23.23 | $23.11 | $21.78 |
| 6 Nov 2020 | $20.71 | $22.97 | $21.98 |
| 27 Nov 2020 | $19.41 | $22.12 | $22.06 |
| 18 Dec 2020 | $19.95 | $20.67 | $22.04 |
| 8 Jan 2021 | $22.82 | $20.17 | $22.36 |
| 29 Jan 2021 | $22.21 | $20.77 | $22.75 |
| 19 Feb 2021 | $22.21 | $21.79 | $22.61 |
| 12 Mar 2021 | $23.28 | $22.42 | $22.36 |
| 1 Apr 2021 | $23.12 | $22.49 | $22.34 |
| 23 Apr 2021 | $24.73 | $22.85 | $22.37 |
| 14 May 2021 | $25.56 | $23.64 | $22.38 |
| 4 Jun 2021 | $22.37 | $23.74 | $22.43 |
| 25 Jun 2021 | $23.42 | $23.62 | $22.50 |
| 16 Jul 2021 | $16.80 | $21.79 | $22.04 |
| 6 Aug 2021 | $17.25 | $19.56 | $21.53 |
| 27 Aug 2021 | $19.43 | $18.32 | $21.30 |
| 17 Sep 2021 | $20.72 | $18.26 | $21.34 |
| 8 Oct 2021 | $21.62 | $19.37 | $21.42 |
| 29 Oct 2021 | $21.51 | $20.55 | $21.40 |
| 19 Nov 2021 | $18.03 | $20.38 | $21.11 |
| 10 Dec 2021 | $16.65 | $19.34 | $20.72 |
| 31 Dec 2021 | $18.28 | $18.49 | $20.43 |
| 21 Jan 2022 | $17.32 | $17.75 | $20.09 |
| 11 Feb 2022 | $18.75 | $18.02 | $19.66 |
| 4 Mar 2022 | $20.70 | $18.77 | $19.33 |
| 25 Mar 2022 | $21.88 | $19.49 | $19.19 |
| 14 Apr 2022 | $23.09 | $20.87 | $19.26 |
| 6 May 2022 | $21.49 | $21.92 | $19.64 |
| 27 May 2022 | $18.40 | $21.38 | $19.78 |
| 17 Jun 2022 | $18.56 | $20.36 | $19.75 |
| 8 Jul 2022 | $22.01 | $19.99 | $19.83 |
| 29 Jul 2022 | $20.92 | $19.98 | $19.85 |
| 19 Aug 2022 | $19.33 | $20.53 | $19.76 |
| 9 Sep 2022 | $17.90 | $20.16 | $19.75 |
| 30 Sep 2022 | $15.68 | $18.69 | $19.74 |
| 21 Oct 2022 | $16.45 | $17.18 | $19.54 |
| 11 Nov 2022 | $16.80 | $16.50 | $19.44 |
| 2 Dec 2022 | $17.39 | $16.39 | $19.32 |
| 23 Dec 2022 | $15.83 | $16.47 | $19.00 |
| 13 Jan 2023 | $16.43 | $16.49 | $18.69 |
| 3 Feb 2023 | $17.55 | $16.62 | $18.29 |
| 24 Feb 2023 | $17.13 | $16.84 | $17.96 |
| 17 Mar 2023 | $17.55 | $17.20 | $17.83 |
| 6 Apr 2023 | $20.48 | $17.82 | $17.86 |
| 28 Apr 2023 | $18.30 | $18.29 | $17.69 |
| 19 May 2023 | $19.79 | $18.94 | $17.54 |
| 9 Jun 2023 | $19.20 | $19.29 | $17.50 |
| 30 Jun 2023 | $19.11 | $19.18 | $17.58 |
| 21 Jul 2023 | $19.69 | $19.30 | $17.78 |
| 11 Aug 2023 | $21.52 | $19.57 | $18.11 |
| 1 Sep 2023 | $22.74 | $20.34 | $18.50 |
| 22 Sep 2023 | $21.48 | $21.08 | $18.85 |
| 13 Oct 2023 | $21.36 | $21.70 | $19.29 |
| 3 Nov 2023 | $21.00 | $21.55 | $19.60 |
| 24 Nov 2023 | $21.68 | $21.24 | $19.86 |
| 15 Dec 2023 | $23.41 | $21.35 | $20.21 |
| 5 Jan 2024 | $23.24 | $22.03 | $20.63 |
| 26 Jan 2024 | $22.12 | $22.54 | $20.86 |
| 16 Feb 2024 | $20.48 | $22.39 | $21.01 |
| 8 Mar 2024 | $22.21 | $22.03 | $21.18 |
| 28 Mar 2024 | $23.73 | $22.05 | $21.46 |
| 19 Apr 2024 | $22.52 | $22.42 | $21.76 |
| 10 May 2024 | $21.37 | $22.93 | $22.00 |
| 31 May 2024 | $21.69 | $22.43 | $22.02 |
| 21 Jun 2024 | $22.20 | $21.95 | $22.03 |
| 12 Jul 2024 | $22.40 | $21.72 | $22.06 |
| 2 Aug 2024 | $24.17 | $22.18 | $22.14 |
| 23 Aug 2024 | $25.88 | $23.58 | $22.56 |
| 13 Sep 2024 | $26.46 | $24.65 | $22.89 |
| 4 Oct 2024 | $26.66 | $25.87 | $23.20 |
| 25 Oct 2024 | $27.87 | $26.61 | $23.50 |
| 15 Nov 2024 | $34.45 | $29.04 | $24.38 |
| 6 Dec 2024 | $35.82 | $31.57 | $25.42 |
| 27 Dec 2024 | $33.81 | $33.81 | $26.28 |
| 17 Jan 2025 | $36.20 | $35.06 | $27.02 |
| 7 Feb 2025 | $33.48 | $34.54 | $27.74 |
| 28 Feb 2025 | $38.69 | $34.50 | $28.65 |
| 21 Mar 2025 | $36.96 | $35.59 | $29.89 |
| 11 Apr 2025 | $35.31 | $36.06 | $30.95 |
| 2 May 2025 | $39.60 | $37.06 | $32.01 |
| 23 May 2025 | $42.39 | $38.00 | $33.35 |
| 13 Jun 2025 | $41.59 | $39.54 | $34.47 |
| 3 Jul 2025 | $46.15 | $41.54 | $35.59 |
| 25 Jul 2025 | $45.60 | $43.61 | $36.95 |
| 15 Aug 2025 | $38.31 | $41.94 | $37.74 |
| 5 Sep 2025 | $37.88 | $40.69 | $38.01 |
| 26 Sep 2025 | $39.04 | $39.11 | $38.28 |
| 17 Oct 2025 | $39.25 | $38.83 | $38.68 |
| 7 Nov 2025 | $40.81 | $38.97 | $38.95 |
| 28 Nov 2025 | $44.17 | $40.16 | $39.63 |
| 19 Dec 2025 | $44.30 | $40.98 | $40.06 |
| 9 Jan 2026 | $44.04 | $42.68 | $40.55 |
| 30 Jan 2026 | $41.36 | $43.57 | $41.11 |
| 20 Feb 2026 | $43.63 | $43.62 | $41.51 |
| 13 Mar 2026 | $41.24 | $43.30 | $41.60 |
| 2 Apr 2026 | $43.88 | $42.70 | $41.58 |
| 24 Apr 2026 | $44.94 | $43.24 | $41.69 |
| 15 May 2026 | $50.13 | $44.36 | $41.94 |
| 5 Jun 2026 | $52.70 | $46.83 | $42.83 |
| 26 Jun 2026 | $54.77 | $49.30 | $43.86 |
| 17 Jul 2026 | $55.92 | $52.34 | $45.01 |
| 7 Aug 2026 | $54.07 | $54.05 | $46.20 |
| 28 Aug 2026 | $54.45 | $54.50 | $47.28 |
| 18 Sep 2026 | $58.36 | $55.39 | $48.30 |
| 9 Oct 2026 | $59.86 | $56.14 | $49.47 |
| 30 Oct 2026 | $69.39 | $59.39 | $50.91 |
| 4 Nov 2026 | $72.75 | $60.38 | $51.32 |
Price stage: Rising from Oct 2025 to Feb 2026; Sideways in Mar 2026; Rising from Apr 2026 to Nov 2026.
Price stage: Rising from Nov 2023 to Apr 2024; Sideways from May 2024 to Jun 2024; Rising from Jun 2024 to Feb 2026; Sideways in Mar 2026; Rising from Apr 2026 to Nov 2026.
Price stage: Falling from Oct 2021 to Feb 2022; Sideways from Feb 2022 to Aug 2022; Sideways from Sep 2022 to Nov 2022; Falling from Dec 2022 to Mar 2023; Sideways from Mar 2023 to Aug 2023; Rising from Sep 2023 to Apr 2024; Sideways from May 2024 to Jun 2024; Rising from Jun 2024 to Nov 2026.
Price stage: Rising from Dec 2017 to Feb 2018; Sideways from Mar 2018 to Jul 2018; Falling from Aug 2018 to Nov 2018; Sideways from Dec 2018 to Jul 2019; Sideways from Aug 2019 to Feb 2020; Falling from Feb 2020 to Apr 2020; Sideways from May 2020 to Oct 2020; Sideways from Nov 2020 to Feb 2021; Rising from Mar 2021 to Jul 2021; Falling from Aug 2021 to Feb 2022; Sideways from Mar 2022 to Aug 2022; Sideways from Sep 2022 to Nov 2022; Falling from Dec 2022 to Mar 2023; Sideways from Apr 2023 to Aug 2023; Rising from Sep 2023 to Nov 2026.
Week by week since 2016: did it beat the S&P 500 over the past 13 weeks?
Ahead in 276 of 527 weeks
| Week | 13-week return vs S&P 500 |
|---|---|
| 8 Jul 2016 | no S&P 500 reading |
| 15 Jul 2016 | no S&P 500 reading |
| 22 Jul 2016 | no S&P 500 reading |
| 29 Jul 2016 | no S&P 500 reading |
| 5 Aug 2016 | no S&P 500 reading |
| 12 Aug 2016 | no S&P 500 reading |
| 19 Aug 2016 | no S&P 500 reading |
| 26 Aug 2016 | no S&P 500 reading |
| 2 Sep 2016 | no S&P 500 reading |
| 9 Sep 2016 | no S&P 500 reading |
| 16 Sep 2016 | no S&P 500 reading |
| 23 Sep 2016 | no S&P 500 reading |
| 30 Sep 2016 | no S&P 500 reading |
| 7 Oct 2016 | +57.8% |
| 14 Oct 2016 | +35.4% |
| 21 Oct 2016 | +34.7% |
| 28 Oct 2016 | +20.6% |
| 4 Nov 2016 | +11.0% |
| 11 Nov 2016 | +54.8% |
| 18 Nov 2016 | +54.2% |
| 25 Nov 2016 | +53.2% |
| 2 Dec 2016 | +49.9% |
| 9 Dec 2016 | +34.4% |
| 16 Dec 2016 | +18.4% |
| 23 Dec 2016 | −1.0% |
| 30 Dec 2016 | +13.2% |
| 6 Jan 2017 | +12.6% |
| 13 Jan 2017 | +57.0% |
| 20 Jan 2017 | +49.1% |
| 27 Jan 2017 | +62.9% |
| 3 Feb 2017 | +60.1% |
| 10 Feb 2017 | +27.7% |
| 17 Feb 2017 | +28.7% |
| 24 Feb 2017 | +20.7% |
| 3 Mar 2017 | +24.3% |
| 10 Mar 2017 | +23.6% |
| 17 Mar 2017 | +25.9% |
| 24 Mar 2017 | +32.1% |
| 31 Mar 2017 | +39.9% |
| 7 Apr 2017 | +30.1% |
| 13 Apr 2017 | +12.6% |
| 21 Apr 2017 | +13.6% |
| 28 Apr 2017 | +16.6% |
| 5 May 2017 | +2.5% |
| 12 May 2017 | −5.4% |
| 19 May 2017 | −16.2% |
| 26 May 2017 | −12.9% |
| 2 Jun 2017 | −19.9% |
| 9 Jun 2017 | −13.5% |
| 16 Jun 2017 | −14.9% |
| 23 Jun 2017 | +9.8% |
| 30 Jun 2017 | +11.1% |
| 7 Jul 2017 | +20.2% |
| 14 Jul 2017 | +20.0% |
| 21 Jul 2017 | +24.6% |
| 28 Jul 2017 | +19.6% |
| 4 Aug 2017 | +19.7% |
| 11 Aug 2017 | +20.5% |
| 18 Aug 2017 | +31.9% |
| 25 Aug 2017 | +39.2% |
| 1 Sep 2017 | +50.7% |
| 8 Sep 2017 | +33.6% |
| 15 Sep 2017 | +40.4% |
| 22 Sep 2017 | +0.3% |
| 29 Sep 2017 | −5.5% |
| 6 Oct 2017 | −3.1% |
| 13 Oct 2017 | −11.2% |
| 20 Oct 2017 | −4.4% |
| 27 Oct 2017 | −8.0% |
| 3 Nov 2017 | −6.0% |
| 10 Nov 2017 | −8.2% |
| 17 Nov 2017 | −6.1% |
| 24 Nov 2017 | −11.3% |
| 1 Dec 2017 | −9.7% |
| 8 Dec 2017 | −3.3% |
| 15 Dec 2017 | −12.3% |
| 22 Dec 2017 | +13.2% |
| 29 Dec 2017 | +19.2% |
| 5 Jan 2018 | +15.5% |
| 12 Jan 2018 | +13.7% |
| 19 Jan 2018 | −6.0% |
| 26 Jan 2018 | +2.5% |
| 2 Feb 2018 | +8.5% |
| 9 Feb 2018 | +7.8% |
| 16 Feb 2018 | +4.7% |
| 23 Feb 2018 | +8.6% |
| 2 Mar 2018 | −16.1% |
| 9 Mar 2018 | −14.5% |
| 16 Mar 2018 | −8.5% |
| 23 Mar 2018 | −19.4% |
| 29 Mar 2018 | −25.7% |
| 6 Apr 2018 | −28.3% |
| 13 Apr 2018 | −28.1% |
| 20 Apr 2018 | −20.5% |
| 27 Apr 2018 | −22.5% |
| 4 May 2018 | −22.3% |
| 11 May 2018 | −35.0% |
| 18 May 2018 | −25.4% |
| 25 May 2018 | −28.4% |
| 1 Jun 2018 | −16.2% |
| 8 Jun 2018 | −20.6% |
| 15 Jun 2018 | −21.4% |
| 22 Jun 2018 | −18.2% |
| 29 Jun 2018 | −5.9% |
| 6 Jul 2018 | −5.5% |
| 13 Jul 2018 | +1.5% |
| 20 Jul 2018 | −2.9% |
| 27 Jul 2018 | −4.1% |
| 3 Aug 2018 | −14.8% |
| 10 Aug 2018 | +0.6% |
| 17 Aug 2018 | −16.1% |
| 24 Aug 2018 | −21.0% |
| 31 Aug 2018 | −14.8% |
| 7 Sep 2018 | −7.8% |
| 14 Sep 2018 | −18.6% |
| 21 Sep 2018 | −22.6% |
| 28 Sep 2018 | −24.8% |
| 5 Oct 2018 | −21.4% |
| 12 Oct 2018 | −24.4% |
| 19 Oct 2018 | −22.4% |
| 26 Oct 2018 | −27.9% |
| 2 Nov 2018 | −11.4% |
| 9 Nov 2018 | −16.4% |
| 16 Nov 2018 | −2.7% |
| 23 Nov 2018 | +10.9% |
| 30 Nov 2018 | +13.1% |
| 7 Dec 2018 | +19.1% |
| 14 Dec 2018 | +34.4% |
| 21 Dec 2018 | +23.3% |
| 28 Dec 2018 | +24.5% |
| 4 Jan 2019 | +30.0% |
| 11 Jan 2019 | +52.5% |
| 18 Jan 2019 | +42.8% |
| 25 Jan 2019 | +61.7% |
| 1 Feb 2019 | +36.2% |
| 8 Feb 2019 | +30.2% |
| 15 Feb 2019 | +22.9% |
| 22 Feb 2019 | +13.1% |
| 1 Mar 2019 | +11.0% |
| 8 Mar 2019 | +8.0% |
| 15 Mar 2019 | +8.6% |
| 22 Mar 2019 | +15.0% |
| 29 Mar 2019 | +8.4% |
| 5 Apr 2019 | +4.2% |
| 12 Apr 2019 | −14.4% |
| 18 Apr 2019 | −16.6% |
| 26 Apr 2019 | −22.1% |
| 3 May 2019 | −20.8% |
| 10 May 2019 | −13.6% |
| 17 May 2019 | −16.2% |
| 24 May 2019 | −6.7% |
| 31 May 2019 | −12.6% |
| 7 Jun 2019 | −17.1% |
| 14 Jun 2019 | −22.5% |
| 21 Jun 2019 | −13.2% |
| 28 Jun 2019 | −13.9% |
| 5 Jul 2019 | −17.5% |
| 12 Jul 2019 | −13.2% |
| 19 Jul 2019 | −0.7% |
| 26 Jul 2019 | −1.7% |
| 2 Aug 2019 | −4.3% |
| 9 Aug 2019 | +3.2% |
| 16 Aug 2019 | +11.3% |
| 23 Aug 2019 | −2.3% |
| 30 Aug 2019 | −4.9% |
| 6 Sep 2019 | −8.2% |
| 13 Sep 2019 | −6.4% |
| 20 Sep 2019 | −9.9% |
| 27 Sep 2019 | −16.6% |
| 4 Oct 2019 | −17.9% |
| 11 Oct 2019 | −19.8% |
| 18 Oct 2019 | −23.1% |
| 25 Oct 2019 | −16.9% |
| 1 Nov 2019 | −23.7% |
| 8 Nov 2019 | −29.5% |
| 15 Nov 2019 | −31.9% |
| 22 Nov 2019 | −28.0% |
| 29 Nov 2019 | −23.7% |
| 6 Dec 2019 | −15.6% |
| 13 Dec 2019 | −12.8% |
| 20 Dec 2019 | −12.9% |
| 27 Dec 2019 | −8.6% |
| 3 Jan 2020 | −9.7% |
| 10 Jan 2020 | +1.0% |
| 17 Jan 2020 | +9.3% |
| 24 Jan 2020 | −4.5% |
| 31 Jan 2020 | +2.3% |
| 7 Feb 2020 | +13.1% |
| 14 Feb 2020 | +17.5% |
| 21 Feb 2020 | +22.3% |
| 28 Feb 2020 | +17.5% |
| 6 Mar 2020 | +13.0% |
| 13 Mar 2020 | +9.2% |
| 20 Mar 2020 | +10.5% |
| 27 Mar 2020 | +16.5% |
| 3 Apr 2020 | +20.1% |
| 9 Apr 2020 | +12.9% |
| 17 Apr 2020 | +11.7% |
| 24 Apr 2020 | +61.2% |
| 1 May 2020 | +52.2% |
| 8 May 2020 | +48.7% |
| 15 May 2020 | +39.2% |
| 22 May 2020 | +28.1% |
| 29 May 2020 | +30.2% |
| 5 Jun 2020 | +12.6% |
| 12 Jun 2020 | +20.6% |
| 19 Jun 2020 | +24.7% |
| 26 Jun 2020 | +14.4% |
| 2 Jul 2020 | +16.3% |
| 10 Jul 2020 | +24.2% |
| 17 Jul 2020 | +14.3% |
| 24 Jul 2020 | −20.7% |
| 31 Jul 2020 | −19.7% |
| 7 Aug 2020 | −28.4% |
| 14 Aug 2020 | −32.3% |
| 21 Aug 2020 | −24.5% |
| 28 Aug 2020 | −27.7% |
| 4 Sep 2020 | −14.9% |
| 11 Sep 2020 | −12.8% |
| 18 Sep 2020 | +3.7% |
| 25 Sep 2020 | −5.4% |
| 2 Oct 2020 | −7.3% |
| 9 Oct 2020 | −13.3% |
| 16 Oct 2020 | −13.5% |
| 23 Oct 2020 | −17.1% |
| 30 Oct 2020 | −11.3% |
| 6 Nov 2020 | −12.0% |
| 13 Nov 2020 | −14.6% |
| 20 Nov 2020 | −19.7% |
| 27 Nov 2020 | −14.0% |
| 4 Dec 2020 | −16.1% |
| 11 Dec 2020 | −18.2% |
| 18 Dec 2020 | −37.2% |
| 24 Dec 2020 | −25.4% |
| 31 Dec 2020 | −26.2% |
| 8 Jan 2021 | −14.5% |
| 15 Jan 2021 | −6.0% |
| 22 Jan 2021 | −11.4% |
| 29 Jan 2021 | −4.9% |
| 5 Feb 2021 | +1.2% |
| 12 Feb 2021 | −1.0% |
| 19 Feb 2021 | +7.7% |
| 26 Feb 2021 | +7.0% |
| 5 Mar 2021 | +13.9% |
| 12 Mar 2021 | +9.6% |
| 19 Mar 2021 | +11.8% |
| 26 Mar 2021 | +2.2% |
| 1 Apr 2021 | +8.0% |
| 9 Apr 2021 | −6.6% |
| 16 Apr 2021 | −11.7% |
| 23 Apr 2021 | +2.9% |
| 30 Apr 2021 | −1.9% |
| 7 May 2021 | −0.5% |
| 14 May 2021 | +10.6% |
| 21 May 2021 | +3.7% |
| 28 May 2021 | −6.3% |
| 4 Jun 2021 | −10.0% |
| 11 Jun 2021 | −9.0% |
| 18 Jun 2021 | −10.8% |
| 25 Jun 2021 | −4.5% |
| 2 Jul 2021 | −29.3% |
| 9 Jul 2021 | −27.9% |
| 16 Jul 2021 | −32.2% |
| 23 Jul 2021 | −37.9% |
| 30 Jul 2021 | −36.6% |
| 6 Aug 2021 | −36.1% |
| 13 Aug 2021 | −35.5% |
| 20 Aug 2021 | −31.5% |
| 27 Aug 2021 | −21.0% |
| 3 Sep 2021 | −18.8% |
| 10 Sep 2021 | −18.1% |
| 17 Sep 2021 | −13.9% |
| 24 Sep 2021 | −17.2% |
| 1 Oct 2021 | +17.8% |
| 8 Oct 2021 | +19.5% |
| 15 Oct 2021 | +26.5% |
| 22 Oct 2021 | +24.9% |
| 29 Oct 2021 | +22.9% |
| 5 Nov 2021 | +6.3% |
| 12 Nov 2021 | −5.8% |
| 19 Nov 2021 | −8.0% |
| 26 Nov 2021 | −14.1% |
| 3 Dec 2021 | −20.0% |
| 10 Dec 2021 | −22.3% |
| 17 Dec 2021 | −16.3% |
| 23 Dec 2021 | −11.3% |
| 31 Dec 2021 | −24.5% |
| 7 Jan 2022 | −19.8% |
| 14 Jan 2022 | −21.2% |
| 21 Jan 2022 | −15.7% |
| 28 Jan 2022 | −13.6% |
| 4 Feb 2022 | +1.3% |
| 11 Feb 2022 | +9.3% |
| 18 Feb 2022 | +15.9% |
| 25 Feb 2022 | +22.9% |
| 4 Mar 2022 | +35.4% |
| 11 Mar 2022 | +36.8% |
| 18 Mar 2022 | +20.9% |
| 25 Mar 2022 | +17.3% |
| 1 Apr 2022 | +29.9% |
| 8 Apr 2022 | +26.8% |
| 14 Apr 2022 | +33.2% |
| 22 Apr 2022 | +32.2% |
| 29 Apr 2022 | +32.5% |
| 6 May 2022 | +22.7% |
| 13 May 2022 | +15.9% |
| 20 May 2022 | +1.1% |
| 27 May 2022 | −3.7% |
| 3 Jun 2022 | −3.0% |
| 10 Jun 2022 | −6.4% |
| 17 Jun 2022 | +4.5% |
| 24 Jun 2022 | +15.4% |
| 1 Jul 2022 | +10.1% |
| 8 Jul 2022 | +8.8% |
| 15 Jul 2022 | +4.4% |
| 22 Jul 2022 | +0.3% |
| 29 Jul 2022 | −6.4% |
| 5 Aug 2022 | −0.4% |
| 12 Aug 2022 | −9.3% |
| 19 Aug 2022 | +0.5% |
| 26 Aug 2022 | +1.5% |
| 2 Sep 2022 | −1.5% |
| 9 Sep 2022 | −5.6% |
| 16 Sep 2022 | −13.0% |
| 23 Sep 2022 | −21.1% |
| 30 Sep 2022 | −21.0% |
| 7 Oct 2022 | −23.4% |
| 14 Oct 2022 | −19.5% |
| 21 Oct 2022 | −15.9% |
| 28 Oct 2022 | −14.9% |
| 4 Nov 2022 | −14.5% |
| 11 Nov 2022 | −7.1% |
| 18 Nov 2022 | −6.3% |
| 25 Nov 2022 | −6.3% |
| 2 Dec 2022 | −6.6% |
| 9 Dec 2022 | −8.6% |
| 16 Dec 2022 | −6.5% |
| 23 Dec 2022 | −6.8% |
| 30 Dec 2022 | −4.8% |
| 6 Jan 2023 | +5.2% |
| 13 Jan 2023 | −6.4% |
| 20 Jan 2023 | −4.1% |
| 27 Jan 2023 | +0.8% |
| 3 Feb 2023 | −2.9% |
| 10 Feb 2023 | +2.1% |
| 17 Feb 2023 | +0.6% |
| 24 Feb 2023 | +2.6% |
| 3 Mar 2023 | −0.7% |
| 10 Mar 2023 | +7.6% |
| 17 Mar 2023 | +8.3% |
| 24 Mar 2023 | +13.4% |
| 31 Mar 2023 | +14.0% |
| 6 Apr 2023 | +13.1% |
| 14 Apr 2023 | +14.9% |
| 21 Apr 2023 | +9.5% |
| 28 Apr 2023 | +2.2% |
| 5 May 2023 | +10.9% |
| 12 May 2023 | +8.4% |
| 19 May 2023 | +10.4% |
| 26 May 2023 | +5.7% |
| 2 Jun 2023 | +6.0% |
| 9 Jun 2023 | +3.7% |
| 16 Jun 2023 | −3.9% |
| 23 Jun 2023 | −2.0% |
| 30 Jun 2023 | −9.8% |
| 7 Jul 2023 | −12.9% |
| 14 Jul 2023 | −9.3% |
| 21 Jul 2023 | −6.1% |
| 28 Jul 2023 | −1.4% |
| 4 Aug 2023 | −4.2% |
| 11 Aug 2023 | +3.9% |
| 18 Aug 2023 | +2.3% |
| 25 Aug 2023 | +10.2% |
| 1 Sep 2023 | +13.1% |
| 8 Sep 2023 | +11.5% |
| 15 Sep 2023 | +13.4% |
| 22 Sep 2023 | +8.8% |
| 29 Sep 2023 | +17.9% |
| 6 Oct 2023 | +17.1% |
| 13 Oct 2023 | +14.1% |
| 20 Oct 2023 | +14.1% |
| 27 Oct 2023 | +11.9% |
| 3 Nov 2023 | +6.3% |
| 10 Nov 2023 | −1.3% |
| 17 Nov 2023 | −3.1% |
| 24 Nov 2023 | −4.9% |
| 1 Dec 2023 | −5.3% |
| 8 Dec 2023 | −3.8% |
| 15 Dec 2023 | +1.5% |
| 22 Dec 2023 | +1.4% |
| 29 Dec 2023 | −1.4% |
| 5 Jan 2024 | −4.3% |
| 12 Jan 2024 | −4.2% |
| 19 Jan 2024 | −8.0% |
| 26 Jan 2024 | −9.2% |
| 2 Feb 2024 | −11.4% |
| 9 Feb 2024 | −17.5% |
| 16 Feb 2024 | −13.9% |
| 23 Feb 2024 | −12.2% |
| 1 Mar 2024 | −10.3% |
| 8 Mar 2024 | −10.2% |
| 15 Mar 2024 | −10.5% |
| 22 Mar 2024 | −10.7% |
| 28 Mar 2024 | −11.1% |
| 5 Apr 2024 | −11.2% |
| 12 Apr 2024 | −6.7% |
| 19 Apr 2024 | −2.5% |
| 26 Apr 2024 | +2.9% |
| 3 May 2024 | −1.5% |
| 10 May 2024 | +1.8% |
| 17 May 2024 | −3.9% |
| 24 May 2024 | −8.7% |
| 31 May 2024 | −5.3% |
| 7 Jun 2024 | −5.8% |
| 14 Jun 2024 | −11.9% |
| 21 Jun 2024 | −11.1% |
| 28 Jun 2024 | −9.4% |
| 5 Jul 2024 | −11.5% |
| 12 Jul 2024 | −11.4% |
| 19 Jul 2024 | −10.5% |
| 26 Jul 2024 | −8.4% |
| 2 Aug 2024 | +6.1% |
| 9 Aug 2024 | +23.9% |
| 16 Aug 2024 | +21.3% |
| 23 Aug 2024 | +19.6% |
| 30 Aug 2024 | +13.1% |
| 6 Sep 2024 | +13.8% |
| 13 Sep 2024 | +18.2% |
| 20 Sep 2024 | +14.6% |
| 27 Sep 2024 | +10.5% |
| 4 Oct 2024 | +17.3% |
| 11 Oct 2024 | +13.6% |
| 18 Oct 2024 | +21.4% |
| 25 Oct 2024 | +12.8% |
| 1 Nov 2024 | +34.0% |
| 8 Nov 2024 | +22.2% |
| 15 Nov 2024 | +25.1% |
| 22 Nov 2024 | +31.7% |
| 29 Nov 2024 | +33.2% |
| 6 Dec 2024 | +29.9% |
| 13 Dec 2024 | +24.9% |
| 20 Dec 2024 | +22.0% |
| 27 Dec 2024 | +26.1% |
| 3 Jan 2025 | +24.1% |
| 10 Jan 2025 | +37.2% |
| 17 Jan 2025 | +23.0% |
| 24 Jan 2025 | +11.2% |
| 31 Jan 2025 | −8.2% |
| 7 Feb 2025 | −8.1% |
| 14 Feb 2025 | −2.5% |
| 21 Feb 2025 | +2.7% |
| 28 Feb 2025 | +7.5% |
| 7 Mar 2025 | +13.0% |
| 14 Mar 2025 | +11.5% |
| 21 Mar 2025 | +15.6% |
| 28 Mar 2025 | +15.2% |
| 4 Apr 2025 | +16.4% |
| 11 Apr 2025 | +6.0% |
| 17 Apr 2025 | +11.9% |
| 25 Apr 2025 | +25.0% |
| 2 May 2025 | +25.3% |
| 9 May 2025 | +14.1% |
| 16 May 2025 | +32.3% |
| 23 May 2025 | +18.5% |
| 30 May 2025 | +12.0% |
| 6 Jun 2025 | +7.5% |
| 13 Jun 2025 | +7.4% |
| 20 Jun 2025 | +3.9% |
| 27 Jun 2025 | +8.3% |
| 3 Jul 2025 | +9.7% |
| 11 Jul 2025 | +10.3% |
| 18 Jul 2025 | +3.7% |
| 25 Jul 2025 | +6.1% |
| 1 Aug 2025 | −15.6% |
| 8 Aug 2025 | −8.6% |
| 15 Aug 2025 | −23.9% |
| 22 Aug 2025 | −20.3% |
| 29 Aug 2025 | −22.5% |
| 5 Sep 2025 | −20.0% |
| 12 Sep 2025 | −16.0% |
| 19 Sep 2025 | −12.4% |
| 26 Sep 2025 | −18.2% |
| 3 Oct 2025 | −20.1% |
| 10 Oct 2025 | −19.7% |
| 17 Oct 2025 | −17.6% |
| 24 Oct 2025 | −21.4% |
| 31 Oct 2025 | −5.9% |
| 7 Nov 2025 | +2.9% |
| 14 Nov 2025 | +4.3% |
| 21 Nov 2025 | +7.9% |
| 28 Nov 2025 | +12.1% |
| 5 Dec 2025 | +11.2% |
| 12 Dec 2025 | +0.7% |
| 19 Dec 2025 | +7.9% |
| 26 Dec 2025 | +14.1% |
| 2 Jan 2026 | +6.6% |
| 9 Jan 2026 | +9.2% |
| 16 Jan 2026 | +7.9% |
| 23 Jan 2026 | +12.6% |
| 30 Jan 2026 | +5.5% |
| 6 Feb 2026 | +4.6% |
| 13 Feb 2026 | +4.0% |
| 20 Feb 2026 | −2.0% |
| 27 Feb 2026 | −0.6% |
| 6 Mar 2026 | −4.4% |
| 13 Mar 2026 | +3.7% |
| 20 Mar 2026 | −2.1% |
| 27 Mar 2026 | −2.0% |
| 2 Apr 2026 | +4.7% |
| 10 Apr 2026 | +2.6% |
| 17 Apr 2026 | −0.6% |
| 24 Apr 2026 | −2.1% |
| 1 May 2026 | +1.5% |
| 8 May 2026 | +2.9% |
| 15 May 2026 | +5.7% |
| 22 May 2026 | +6.8% |
| 29 May 2026 | +4.3% |
| 5 Jun 2026 | +17.1% |
| 12 Jun 2026 | +16.8% |
| 18 Jun 2026 | +10.6% |
| 26 Jun 2026 | +16.9% |
| 2 Jul 2026 | +13.7% |
| 10 Jul 2026 | +16.5% |
| 17 Jul 2026 | +19.9% |
| 24 Jul 2026 | +19.7% |
| 31 Jul 2026 | +17.7% |
| 7 Aug 2026 | +7.4% |
| 14 Aug 2026 | −2.8% |
| 21 Aug 2026 | +5.1% |
| 28 Aug 2026 | +6.2% |
| 4 Sep 2026 | +7.5% |
| 11 Sep 2026 | +2.6% |
| 18 Sep 2026 | +10.4% |
| 25 Sep 2026 | +0.4% |
| 2 Oct 2026 | +1.2% |
| 9 Oct 2026 | +2.8% |
| 16 Oct 2026 | +8.6% |
| 23 Oct 2026 | +13.7% |
| 30 Oct 2026 | +29.7% |
| 4 Nov 2026 | +35.4% |
Over the last 10 years the share price moved +793% while the S&P 500 moved +261%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week.
This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.
What dividend does Exelixis pay?
Exelixis, Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes.
Which stock lists is Exelixis on?
Exelixis is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list.
Is Exelixis profitable?
Exelixis, Inc. earned $212 M of net profit in the Jun 2026 quarter, +14.7% on the same quarter a year earlier. That is the 5th quarter in a row of profit growth. Full-year FY25 profit was $783 M. Over 4 years profit has grown 35.7% a year on average. That is 33.7% of the quarter's revenue.
Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.
The same quarter a year earlier earned $194 M.
For the full year, FY25 profit was $783 M (+50.1% on the year before).
FY25 profit $783 M (+50.1% on the year before), 35.7% a year over 4 years
- Net profit $783 M
| Quarter | Net profit |
|---|---|
| FY21 | $231 M |
| FY22 | $182 M |
| FY23 | $208 M |
| FY24 | $521 M |
| FY25 | $783 M |
Growth on a year earlier
- Growth on a year earlier 50.1%
| Quarter | Growth on a year earlier |
|---|---|
| FY21 | – |
| FY22 | −21.1% |
| FY23 | 14% |
| FY24 | 150.9% |
| FY25 | 50.1% |
Jun 2026: $212 M (+14.7% on a year earlier), the 5th quarter in a row of growth
- Net profit (quarterly) $212 M
| Quarter | Net profit (quarterly) |
|---|---|
| Mar 2024 | $37.3 M |
| Jun 2024 | $226 M |
| Sep 2024 | $118 M |
| Dec 2024 | $140 M |
| Mar 2025 | $160 M |
| Apr 2025 | $160 M |
| Jun 2025 | $185 M |
| Sep 2025 | $194 M |
| Dec 2025 | $245 M |
| Mar 2026 | $210 M |
| Apr 2026 | $210 M |
| Jun 2026 | $212 M |
Growth on a year earlier
- Growth on a year earlier 14.7%
| Quarter | Growth on a year earlier |
|---|---|
| Mar 2024 | −6.8% |
| Jun 2024 | 178.5% |
| Sep 2024 | 11,232.7% |
| Dec 2024 | 63.5% |
| Mar 2025 | 327.7% |
| Apr 2025 | 327.7% |
| Jun 2025 | −18.3% |
| Sep 2025 | 64.1% |
| Dec 2025 | 74.8% |
| Mar 2026 | 31.9% |
| Apr 2026 | 31.9% |
| Jun 2026 | 14.7% |
Why profit moved: revenue changed +10.6% on a year earlier and the margin moved +1.9 percentage points. Sales did the work, and the margin was about flat.
On average over the last four quarters, profit changed +38.3% and revenue +9.1%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit.
How much revenue does Exelixis make, and is it growing?
Exelixis, Inc. reported $629 M of revenue in the Jun 2026 quarter, +10.6% on the same quarter a year earlier. That is the 5th quarter in a row with growth on the year before. Over 4 years it has grown 12.8% a year on average. The last full year, FY25, came in at $2.3 B.
Revenue is everything the company billed its customers in the period.
The last four reported quarters add to $2.4 B.
FY25 revenue was $2.3 B, +7.0% on the year before.
FY25 revenue $2.3 B (+7.0% on the year before), 12.8% a year over 4 years
- Revenue $2.3 B
| Quarter | Revenue |
|---|---|
| FY21 | $1.4 B |
| FY22 | $1.6 B |
| FY23 | $1.8 B |
| FY24 | $2.2 B |
| FY25 | $2.3 B |
Growth on a year earlier
- Growth on a year earlier 7%
| Quarter | Growth on a year earlier |
|---|---|
| FY21 | – |
| FY22 | 12.3% |
| FY23 | 13.6% |
| FY24 | 18.5% |
| FY25 | 7% |
Jun 2026: $629 M (+10.6% on a year earlier), the 5th quarter in a row of growth
- Revenue (quarterly) $629 M
| Quarter | Revenue (quarterly) |
|---|---|
| Mar 2024 | $425 M |
| Jun 2024 | $637 M |
| Sep 2024 | $540 M |
| Dec 2024 | $567 M |
| Mar 2025 | $555 M |
| Apr 2025 | $555 M |
| Jun 2025 | $568 M |
| Sep 2025 | $598 M |
| Dec 2025 | $599 M |
| Mar 2026 | $611 M |
| Apr 2026 | $611 M |
| Jun 2026 | $629 M |
Growth on a year earlier
- Growth on a year earlier 10.6%
| Quarter | Growth on a year earlier |
|---|---|
| Mar 2024 | 4% |
| Jun 2024 | 35.6% |
| Sep 2024 | 14.3% |
| Dec 2024 | 18.2% |
| Mar 2025 | 30.6% |
| Apr 2025 | 30.6% |
| Jun 2025 | −10.8% |
| Sep 2025 | 10.8% |
| Dec 2025 | 5.6% |
| Mar 2026 | 10% |
| Apr 2026 | 10% |
| Jun 2026 | 10.6% |
Recent pace: the last four quarters grew +9.1% on average, against 12.8% a year over the longer run, so this year is growing slower than its own long-run rate.
Is growth speeding up? Revenue over the last 12 months grew +7.6%, against +6.3% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +25.8%, against +29.7% a year (rolling over).
How much of every $100 of sales does Exelixis keep?
Exelixis, Inc.'s operating margin was 39.5% in the Jun 2026 quarter, 1.9 percentage points higher than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Over the last four quarters it has moved −3.4 percentage points. Across 5 years it has been between 9.3% and 38.5%.
Operating margin is what is left from every $100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.
The latest quarter is above every full year in that period.
Across 5 years it has been between 9.3% and 38.5%, and FY25's 38.5% is the highest of them.
Why the margin moved: operating margin changed −3.4 percentage points on the year while gross margin changed −0.2 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales.
When margins are at a record, every ratio built on profit looks better than usual, so watch whether they hold.
FY25: 38.5%, the highest in a range of 9.3% to 38.5% over 5 years
- Operating margin 38.5%
| Quarter | Operating margin |
|---|---|
| FY21 | 20% |
| FY22 | 12.5% |
| FY23 | 9.3% |
| FY24 | 31.8% |
| FY25 | 38.5% |
Change on the year before (points)
- Change on the year before (points) +6.7 pts
| Quarter | Change on the year before (points) |
|---|---|
| FY21 | – |
| FY22 | −7.5 pts |
| FY23 | −3.2 pts |
| FY24 | +22.5 pts |
| FY25 | +6.7 pts |
Jun 2026: operating margin 39.5% (+1.9 points on a year earlier)
- Operating margin 39.5%
| Quarter | Operating margin |
|---|---|
| Mar 2024 | 14.7% |
| Jun 2024 | 43.4% |
| Sep 2024 | 34.8% |
| Dec 2024 | 28.8% |
| Mar 2025 | 33.6% |
| Apr 2025 | 33.6% |
| Jun 2025 | 37.6% |
| Sep 2025 | 42.9% |
| Dec 2025 | 39.4% |
| Mar 2026 | 41.1% |
| Apr 2026 | 41.1% |
| Jun 2026 | 39.5% |
Change on a year earlier (points)
- Change on a year earlier (points) +1.9 pts
| Quarter | Change on a year earlier (points) |
|---|---|
| Mar 2024 | +7.6 pts |
| Jun 2024 | +26.8 pts |
| Sep 2024 | +38.5 pts |
| Dec 2024 | +11.7 pts |
| Mar 2025 | +18.9 pts |
| Apr 2025 | +18.9 pts |
| Jun 2025 | −5.8 pts |
| Sep 2025 | +8.1 pts |
| Dec 2025 | +10.6 pts |
| Mar 2026 | +7.5 pts |
| Apr 2026 | +7.5 pts |
| Jun 2026 | +1.9 pts |
Is Exelixis' profit turning into cash?
Over the last 3 years, 127% of Exelixis, Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $884 M of operating cash against $783 M of profit. After $8.4 M of spending on assets, $876 M was left over as free cash.
The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.
Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.
FY25: operating cash $884 M against profit $783 M; 127% of 3 years' profit came in as cash
- Operating cash $884 M
- Net profit $783 M
- Free cash $876 M
| Quarter | Operating cash | Net profit | Free cash |
|---|---|---|---|
| FY21 | $401 M | $231 M | $347 M |
| FY22 | $363 M | $182 M | $335 M |
| FY23 | $333 M | $208 M | $293 M |
| FY24 | $700 M | $521 M | $672 M |
| FY25 | $884 M | $783 M | $876 M |
Jun 2026: operating cash $308 M = 145% of the quarter's profit
- Operating cash (quarterly) $308 M
| Quarter | Operating cash (quarterly) |
|---|---|
| Mar 2024 | $68.8 M |
| Jun 2024 | $120 M |
| Sep 2024 | $271 M |
| Dec 2024 | $240 M |
| Mar 2025 | $211 M |
| Apr 2025 | $211 M |
| Jun 2025 | $49.0 M |
| Sep 2025 | $290 M |
| Dec 2025 | $334 M |
| Mar 2026 | $252 M |
| Apr 2026 | $252 M |
| Jun 2026 | $308 M |
Operating cash as % of profit
- Operating cash as % of profit 145%
| Quarter | Operating cash as % of profit |
|---|---|
| Mar 2024 | 184% |
| Jun 2024 | 53% |
| Sep 2024 | 230% |
| Dec 2024 | 172% |
| Mar 2025 | 132% |
| Apr 2025 | 132% |
| Jun 2025 | 27% |
| Sep 2025 | 150% |
| Dec 2025 | 136% |
| Mar 2026 | 120% |
| Apr 2026 | 120% |
| Jun 2026 | 145% |
Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.
What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building.
Where does Exelixis' cash go?
Exelixis, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $77.3 M on assets over the last 3 years. Averaged over those years that is 1.1% of FY25 revenue a year.
Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.
Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.
Spending on assets: $77.3 M over the last 3 years.
FY25: capex $8.4 M, down from the year before
- Capex $8.4 M
| Quarter | Capex |
|---|---|
| FY21 | $54.2 M |
| FY22 | $27.7 M |
| FY23 | $40.5 M |
| FY24 | $28.4 M |
| FY25 | $8.4 M |
Jun 2026: capex $6.8 M in the quarter
- Capex (quarterly) $6.8 M
| Quarter | Capex (quarterly) |
|---|---|
| Mar 2024 | $9.7 M |
| Jun 2024 | $6.6 M |
| Sep 2024 | $8.2 M |
| Dec 2024 | $4.0 M |
| Mar 2025 | $3.0 M |
| Apr 2025 | $3.0 M |
| Jun 2025 | $2.8 M |
| Sep 2025 | $1.5 M |
| Dec 2025 | $1.2 M |
| Mar 2026 | $1.5 M |
| Apr 2026 | $1.5 M |
| Jun 2026 | $6.8 M |
Free cash
- Free cash $301 M
| Quarter | Free cash |
|---|---|
| Mar 2024 | $59.1 M |
| Jun 2024 | $113 M |
| Sep 2024 | $263 M |
| Dec 2024 | $236 M |
| Mar 2025 | $208 M |
| Apr 2025 | $208 M |
| Jun 2025 | $46.2 M |
| Sep 2025 | $289 M |
| Dec 2025 | $332 M |
| Mar 2026 | $250 M |
| Apr 2026 | $250 M |
| Jun 2026 | $301 M |
In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.
What is Exelixis' P/E ratio, and how does it compare with its own history?
Exelixis, Inc.'s P/E is 21.7×, in the middle of its own history: higher than 54% of past readings. Its usual P/E (the middle reading) is 21.1×, over 4.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.
P/E is the share price divided by a year's profit per share: how many dollars the market pays for each dollar of yearly profit.
P/E 21.7× against a usual 21.1×: in the middle of its own history: higher than 54% of past readings
- P/E 22.0×
- Median 21.1×
| Week | P/E | Median |
|---|---|---|
| 1 Apr 2022 | 24.5× | 21.1× |
| 14 Apr 2022 | 24.7× | 21.1× |
| 29 Apr 2022 | 23.9× | 21.1× |
| 13 May 2022 | 21.5× | 21.1× |
| 27 May 2022 | 19.7× | 21.1× |
| 10 Jun 2022 | 19.4× | 21.1× |
| 24 Jun 2022 | 23.8× | 21.1× |
| 8 Jul 2022 | 25.9× | 21.1× |
| 22 Jul 2022 | 24.5× | 21.1× |
| 5 Aug 2022 | 25.3× | 21.1× |
| 19 Aug 2022 | 22.7× | 21.1× |
| 2 Sep 2022 | 21.1× | 21.1× |
| 16 Sep 2022 | 20.2× | 21.1× |
| 30 Sep 2022 | 16.4× | 21.1× |
| 14 Oct 2022 | 16.4× | 21.1× |
| 28 Oct 2022 | 17.4× | 21.1× |
| 11 Nov 2022 | 17.6× | 21.1× |
| 25 Nov 2022 | 17.7× | 21.1× |
| 9 Dec 2022 | 16.5× | 21.1× |
| 23 Dec 2022 | 16.5× | 21.1× |
| 6 Jan 2023 | 30.6× | 21.1× |
| 20 Jan 2023 | 29.7× | 21.1× |
| 3 Feb 2023 | 31.1× | 21.1× |
| 17 Feb 2023 | 31.0× | 21.1× |
| 3 Mar 2023 | 30.4× | 21.1× |
| 17 Mar 2023 | 31.1× | 21.1× |
| 31 Mar 2023 | 41.0× | 21.1× |
| 14 Apr 2023 | 41.0× | 21.1× |
| 28 Apr 2023 | 38.6× | 21.1× |
| 12 May 2023 | 40.5× | 21.1× |
| 26 May 2023 | 40.4× | 21.1× |
| 9 Jun 2023 | 40.5× | 21.1× |
| 23 Jun 2023 | 41.9× | 21.1× |
| 7 Jul 2023 | 38.3× | 21.1× |
| 21 Jul 2023 | 39.1× | 21.1× |
| 4 Aug 2023 | 40.2× | 21.1× |
| 18 Aug 2023 | 41.9× | 21.1× |
| 1 Sep 2023 | 45.1× | 21.1× |
| 15 Sep 2023 | 43.3× | 21.1× |
| 29 Sep 2023 | 43.4× | 21.1× |
| 13 Oct 2023 | 63.2× | 21.1× |
| 27 Oct 2023 | 63.2× | 21.1× |
| 10 Nov 2023 | 63.2× | 21.1× |
| 24 Nov 2023 | 63.2× | 21.1× |
| 8 Dec 2023 | 63.2× | 21.1× |
| 22 Dec 2023 | 63.2× | 21.1× |
| 5 Jan 2024 | 35.9× | 21.1× |
| 19 Jan 2024 | 34.7× | 21.1× |
| 2 Feb 2024 | 33.2× | 21.1× |
| 16 Feb 2024 | 31.6× | 21.1× |
| 1 Mar 2024 | 34.4× | 21.1× |
| 15 Mar 2024 | 35.5× | 21.1× |
| 28 Mar 2024 | 36.7× | 21.1× |
| 12 Apr 2024 | 35.3× | 21.1× |
| 26 Apr 2024 | 36.6× | 21.1× |
| 10 May 2024 | 33.0× | 21.1× |
| 24 May 2024 | 31.8× | 21.1× |
| 7 Jun 2024 | 33.8× | 21.1× |
| 21 Jun 2024 | 34.3× | 21.1× |
| 5 Jul 2024 | 18.9× | 21.1× |
| 19 Jul 2024 | 19.4× | 21.1× |
| 2 Aug 2024 | 20.7× | 21.1× |
| 16 Aug 2024 | 22.6× | 21.1× |
| 30 Aug 2024 | 22.3× | 21.1× |
| 13 Sep 2024 | 22.7× | 21.1× |
| 27 Sep 2024 | 22.3× | 21.1× |
| 11 Oct 2024 | 16.8× | 21.1× |
| 25 Oct 2024 | 17.8× | 21.1× |
| 8 Nov 2024 | 23.2× | 21.1× |
| 22 Nov 2024 | 22.8× | 21.1× |
| 6 Dec 2024 | 22.9× | 21.1× |
| 20 Dec 2024 | 21.3× | 21.1× |
| 3 Jan 2025 | 19.2× | 21.1× |
| 17 Jan 2025 | 20.4× | 21.1× |
| 31 Jan 2025 | 18.7× | 21.1× |
| 14 Feb 2025 | 19.8× | 21.1× |
| 28 Feb 2025 | 21.9× | 21.1× |
| 14 Mar 2025 | 20.7× | 21.1× |
| 28 Mar 2025 | 20.7× | 21.1× |
| 11 Apr 2025 | 17.8× | 21.1× |
| 25 Apr 2025 | 18.8× | 21.1× |
| 9 May 2025 | 18.2× | 21.1× |
| 23 May 2025 | 21.3× | 21.1× |
| 6 Jun 2025 | 21.6× | 21.1× |
| 20 Jun 2025 | 20.3× | 21.1× |
| 3 Jul 2025 | 20.6× | 21.1× |
| 18 Jul 2025 | 19.9× | 21.1× |
| 1 Aug 2025 | 16.6× | 21.1× |
| 15 Aug 2025 | 17.1× | 21.1× |
| 29 Aug 2025 | 16.7× | 21.1× |
| 12 Sep 2025 | 17.5× | 21.1× |
| 26 Sep 2025 | 17.4× | 21.1× |
| 10 Oct 2025 | 15.6× | 21.1× |
| 24 Oct 2025 | 15.8× | 21.1× |
| 7 Nov 2025 | 16.7× | 21.1× |
| 21 Nov 2025 | 17.4× | 21.1× |
| 5 Dec 2025 | 18.1× | 21.1× |
| 19 Dec 2025 | 18.1× | 21.1× |
| 2 Jan 2026 | 15.7× | 21.1× |
| 16 Jan 2026 | 15.8× | 21.1× |
| 30 Jan 2026 | 14.9× | 21.1× |
| 13 Feb 2026 | 15.8× | 21.1× |
| 27 Feb 2026 | 15.8× | 21.1× |
| 13 Mar 2026 | 14.8× | 21.1× |
| 27 Mar 2026 | 14.9× | 21.1× |
| 10 Apr 2026 | 13.9× | 21.1× |
| 24 Apr 2026 | 14.1× | 21.1× |
| 8 May 2026 | 15.2× | 21.1× |
| 22 May 2026 | 15.8× | 21.1× |
| 5 Jun 2026 | 16.6× | 21.1× |
| 18 Jun 2026 | 16.3× | 21.1× |
| 2 Jul 2026 | 16.9× | 21.1× |
| 17 Jul 2026 | 16.9× | 21.1× |
| 31 Jul 2026 | 16.0× | 21.1× |
| 14 Aug 2026 | 15.5× | 21.1× |
| 28 Aug 2026 | 16.5× | 21.1× |
| 11 Sep 2026 | 17.0× | 21.1× |
| 25 Sep 2026 | 17.6× | 21.1× |
| 9 Oct 2026 | 18.1× | 21.1× |
| 23 Oct 2026 | 19.5× | 21.1× |
| 4 Nov 2026 | 22.0× | 21.1× |
Earnings per share, 12 months
- Earnings per share, 12 months $3.31
| Week | Earnings per share, 12 months |
|---|---|
| 1 Apr 2022 | – |
| 14 Apr 2022 | – |
| 29 Apr 2022 | – |
| 13 May 2022 | – |
| 27 May 2022 | – |
| 10 Jun 2022 | – |
| 24 Jun 2022 | $0.94 |
| 8 Jul 2022 | $0.94 |
| 22 Jul 2022 | $0.94 |
| 5 Aug 2022 | $0.94 |
| 19 Aug 2022 | $0.94 |
| 2 Sep 2022 | $0.94 |
| 16 Sep 2022 | $0.94 |
| 30 Sep 2022 | $0.96 |
| 14 Oct 2022 | $0.96 |
| 28 Oct 2022 | $0.96 |
| 11 Nov 2022 | $0.96 |
| 25 Nov 2022 | $0.96 |
| 9 Dec 2022 | $0.96 |
| 23 Dec 2022 | $0.96 |
| 6 Jan 2023 | $0.96 |
| 20 Jan 2023 | $0.96 |
| 3 Feb 2023 | $0.96 |
| 17 Feb 2023 | $0.96 |
| 3 Mar 2023 | $0.96 |
| 17 Mar 2023 | $0.96 |
| 31 Mar 2023 | $0.47 |
| 14 Apr 2023 | $0.47 |
| 28 Apr 2023 | $0.47 |
| 12 May 2023 | $0.47 |
| 26 May 2023 | $0.47 |
| 9 Jun 2023 | $0.47 |
| 23 Jun 2023 | $0.50 |
| 7 Jul 2023 | $0.50 |
| 21 Jul 2023 | $0.50 |
| 4 Aug 2023 | $0.50 |
| 18 Aug 2023 | $0.50 |
| 1 Sep 2023 | $0.50 |
| 15 Sep 2023 | $0.50 |
| 29 Sep 2023 | $0.50 |
| 13 Oct 2023 | $0.50 |
| 27 Oct 2023 | $0.50 |
| 10 Nov 2023 | $0.50 |
| 24 Nov 2023 | $0.50 |
| 8 Dec 2023 | $0.50 |
| 22 Dec 2023 | $0.50 |
| 5 Jan 2024 | $0.28 |
| 19 Jan 2024 | $0.28 |
| 2 Feb 2024 | $0.28 |
| 16 Feb 2024 | $0.28 |
| 1 Mar 2024 | $0.28 |
| 15 Mar 2024 | $0.28 |
| 28 Mar 2024 | $0.65 |
| 12 Apr 2024 | $0.65 |
| 26 Apr 2024 | $0.65 |
| 10 May 2024 | $0.65 |
| 24 May 2024 | $0.65 |
| 7 Jun 2024 | $0.65 |
| 21 Jun 2024 | $0.65 |
| 5 Jul 2024 | $0.65 |
| 19 Jul 2024 | $0.65 |
| 2 Aug 2024 | $0.65 |
| 16 Aug 2024 | $0.65 |
| 30 Aug 2024 | $0.65 |
| 13 Sep 2024 | $0.65 |
| 27 Sep 2024 | $1.17 |
| 11 Oct 2024 | $1.17 |
| 25 Oct 2024 | $1.17 |
| 8 Nov 2024 | $1.17 |
| 22 Nov 2024 | $1.17 |
| 6 Dec 2024 | $1.17 |
| 20 Dec 2024 | $1.17 |
| 3 Jan 2025 | $1.56 |
| 17 Jan 2025 | $1.56 |
| 31 Jan 2025 | $1.56 |
| 14 Feb 2025 | $1.56 |
| 28 Feb 2025 | $1.56 |
| 14 Mar 2025 | $1.56 |
| 28 Mar 2025 | $1.77 |
| 11 Apr 2025 | $1.77 |
| 25 Apr 2025 | $1.77 |
| 9 May 2025 | $1.77 |
| 23 May 2025 | $1.77 |
| 6 Jun 2025 | $1.77 |
| 20 Jun 2025 | $1.77 |
| 3 Jul 2025 | $1.99 |
| 18 Jul 2025 | $1.99 |
| 1 Aug 2025 | $1.99 |
| 15 Aug 2025 | $1.99 |
| 29 Aug 2025 | $1.99 |
| 12 Sep 2025 | $1.99 |
| 26 Sep 2025 | $2.24 |
| 10 Oct 2025 | $2.24 |
| 24 Oct 2025 | $2.24 |
| 7 Nov 2025 | $2.24 |
| 21 Nov 2025 | $2.24 |
| 5 Dec 2025 | $2.24 |
| 19 Dec 2025 | $2.24 |
| 2 Jan 2026 | $2.45 |
| 16 Jan 2026 | $2.45 |
| 30 Jan 2026 | $2.45 |
| 13 Feb 2026 | $2.45 |
| 27 Feb 2026 | $2.45 |
| 13 Mar 2026 | $2.45 |
| 27 Mar 2026 | $2.78 |
| 10 Apr 2026 | $2.78 |
| 24 Apr 2026 | $2.78 |
| 8 May 2026 | $2.78 |
| 22 May 2026 | $2.78 |
| 5 Jun 2026 | $2.78 |
| 18 Jun 2026 | $2.78 |
| 2 Jul 2026 | $3.18 |
| 17 Jul 2026 | $3.18 |
| 31 Jul 2026 | $3.18 |
| 14 Aug 2026 | $3.18 |
| 28 Aug 2026 | $3.18 |
| 11 Sep 2026 | $3.18 |
| 25 Sep 2026 | $3.31 |
| 9 Oct 2026 | $3.31 |
| 23 Oct 2026 | $3.31 |
| 4 Nov 2026 | $3.31 |
PEG 1.51 at the Jun 2026 quarter end: above 1.0, so the P/E is bigger than the earnings growth rate
- PEG 1.51×
- PEG = 1.0 1.00×
| Quarter | PEG | PEG = 1.0 |
|---|---|---|
| Sep 2021 | 0.71× | 1.00× |
| Dec 2021 | 1.05× | 1.00× |
| Mar 2022 | 0.74× | 1.00× |
| Jun 2022 | 0.61× | 1.00× |
| Sep 2022 | 0.46× | 1.00× |
| Dec 2022 | 0.83× | 1.00× |
| Mar 2023 | 1.00× | 1.00× |
| Jun 2023 | 0.80× | 1.00× |
| Sep 2023 | 1.18× | 1.00× |
| Dec 2023 | 0.89× | 1.00× |
| Mar 2024 | 0.62× | 1.00× |
| Jun 2024 | 0.54× | 1.00× |
| Sep 2024 | 0.70× | 1.00× |
| Dec 2024 | 0.50× | 1.00× |
| Mar 2025 | 1.10× | 1.00× |
| Apr 2025 | 1.10× | 1.00× |
| Jun 2025 | 0.79× | 1.00× |
| Sep 2025 | 0.70× | 1.00× |
| Dec 2025 | 0.53× | 1.00× |
| Mar 2026 | 1.39× | 1.00× |
| Apr 2026 | 1.39× | 1.00× |
| Jun 2026 | 1.51× | 1.00× |
Why the multiple is where it is: over the past year earnings per share moved +58.0% while the price moved +78.3%. The price did better than earnings, which pushed the multiple up within its own range.
Where the price move came from: over 3 years the price moved +51.3% a year; about +127.8% a year came from earnings growth and about −76.5 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.
In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple.
Is the Exelixis business getting better or worse?
Exelixis, Inc.'s business is growing steadily. Revenue, profit and EPS growth have stayed positive throughout, and ROCE is steady at 43.1%. This is based on 12 quarters of 4 measures.
Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.
Growth year by year: revenue +7.0% in FY25, profit +50.1%
- Revenue growth 7.0%
| Quarter | Revenue growth |
|---|---|
| FY21 | – |
| FY22 | 12.3% |
| FY23 | 13.6% |
| FY24 | 18.5% |
| FY25 | 7% |
Profit growth, EPS growth
- Profit growth 50.1%
- EPS growth 58%
| Quarter | Profit growth | EPS growth |
|---|---|---|
| FY21 | – | – |
| FY22 | −21.1% | −22.2% |
| FY23 | 14% | 16.1% |
| FY24 | 150.9% | 170.8% |
| FY25 | 50.1% | 58% |
Three growth lines over twelve quarters: revenue stabilising, profit rolling over
- Revenue 7.6%
| Quarter | Revenue |
|---|---|
| Mar 2024 | 11% |
| Jun 2024 | 17.5% |
| Sep 2024 | 17.3% |
| Dec 2024 | 18.5% |
| Mar 2025 | 24.5% |
| Apr 2025 | 10.1% |
| Jun 2025 | 7.9% |
| Sep 2025 | 5% |
| Dec 2025 | 0.9% |
| Mar 2026 | 7.1% |
| Apr 2026 | 7.7% |
| Jun 2026 | 7.6% |
Profit, EPS
- Profit 25.8%
- EPS 35.2%
| Quarter | Profit | EPS |
|---|---|---|
| Mar 2024 | 33.4% | 36.5% |
| Jun 2024 | 113.1% | 131.6% |
| Sep 2024 | 300% | 300% |
| Dec 2024 | 150.9% | 173.6% |
| Mar 2025 | 213.9% | 240% |
| Apr 2025 | 64.9% | 70.3% |
| Jun 2025 | 37.9% | 43.1% |
| Sep 2025 | 33.8% | 38.2% |
| Dec 2025 | 21.6% | 26.4% |
| Mar 2026 | 44.4% | 51.7% |
| Apr 2026 | 33.4% | 42% |
| Jun 2026 | 25.8% | 35.2% |
ROCE: the return line, worked out each quarter
- ROCE 43.1%
| Quarter | ROCE |
|---|---|
| Mar 2024 | 7.8% |
| Jun 2024 | 15.4% |
| Sep 2024 | 23.5% |
| Dec 2024 | 27.1% |
| Mar 2025 | 33.5% |
| Apr 2025 | 29.8% |
| Jun 2025 | 30.6% |
| Sep 2025 | 33.8% |
| Dec 2025 | 36.6% |
| Mar 2026 | 41.1% |
| Apr 2026 | 43.6% |
| Jun 2026 | 43.1% |
Why it matters: steady growth with healthy returns is how a business compounds over time.
Compound annual growth rate (%)
Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.
| Measure | 1yr | 3yr | 5yr | 10yr |
|---|---|---|---|---|
| Revenue | +7.0% | +12.9% | — | — |
| Profit | +50.1% | +62.5% | — | — |
| EPS | +58.0% | +70.6% | — | — |
| Stock price | +78.3% | +51.3% | +30.3% | +19.8% |
How much does Exelixis earn on its capital?
Exelixis, Inc. earned a ROE of 36% in FY25. That is up from a low of 7% in FY22. Its return on capital used (ROIC) is 66.8 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 33.7% net margin and 0.82× asset turnover (sales divided by assets).
Return on equity (ROE) is the profit the business earns on its shareholders’ money. We do not have the full capital split, so ROE is the longest history we can draw here.
Why the return is what it is (FY25): a 33.7% net margin × 0.82× asset turnover × 1.32× leverage (assets divided by equity) ≈ 36.5% on equity. The margin does most of the work; borrowing plays a small part, so this return is earned, not borrowed.
The key test, return on capital used minus the cost of capital: 73.3% − 6.5% = +66.8 percentage points. The 6.5% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. A gap this wide means each dollar put back into the business creates more than a dollar of value.
The 73.3% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 56.0%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method.
FY25: ROE 36%, the climb back from FY22's 7%
- ROE 36.2%
- ROIC (annual) 56%
- Cost of capital 6.5%
| Quarter | ROE | ROIC (annual) | Cost of capital |
|---|---|---|---|
| FY21 | 10.5% | 29.5% | 6.5% |
| FY22 | 7.3% | 14.3% | 6.5% |
| FY23 | 9.2% | 9.6% | 6.5% |
| FY24 | 23.2% | 37.2% | 6.5% |
| FY25 | 36.2% | 56% | 6.5% |
Jun 2026: ROIC 61.6% (last 12 months) against a 6.5% cost of capital
- ROIC (12 months) 61.6%
- ROE (12 months) 41.1%
- Cost of capital 6.5%
| Quarter | ROIC (12 months) | ROE (12 months) | Cost of capital |
|---|---|---|---|
| Mar 2024 | 10.6% | 14.8% | 6.5% |
| Jun 2024 | 12.2% | 6.8% | 6.5% |
| Sep 2024 | 23.7% | 42.6% | 6.5% |
| Dec 2024 | 34.9% | 21.5% | 6.5% |
| Mar 2025 | 39.6% | 24.8% | 6.5% |
| Apr 2025 | 47.4% | 7.5% | 6.5% |
| Jun 2025 | 42.5% | 29.2% | 6.5% |
| Sep 2025 | 44.1% | 35.5% | 6.5% |
| Dec 2025 | 48.9% | 36.9% | 6.5% |
| Mar 2026 | 55% | 45.3% | 6.5% |
| Apr 2026 | 59.2% | 10.4% | 6.5% |
| Jun 2026 | 61.6% | 41.1% | 6.5% |
Does Exelixis have too much debt?
Exelixis, Inc. has total debt of $166 M against shareholder equity of $1.8 B as of Jun 2026, so its debt is 0.09× its equity, which is very little. Year by year, that ratio went from 0.03 in FY21 to 0.09 in FY25. So the returns on this page come from the business, not from borrowed money.
Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.
FY25: debt $201 M, 0.09× equity
- Total debt $201 M
| Quarter | Total debt |
|---|---|
| FY21 | $56.4 M |
| FY22 | $208 M |
| FY23 | $216 M |
| FY24 | $216 M |
| FY25 | $201 M |
Debt-to-equity
- Debt-to-equity 0.09×
| Quarter | Debt-to-equity |
|---|---|
| FY21 | 0.03× |
| FY22 | 0.08× |
| FY23 | 0.10× |
| FY24 | 0.10× |
| FY25 | 0.09× |
Jun 2026: debt $166 M, debt-to-equity 0.09
- Total debt (quarterly) $166 M
| Quarter | Total debt (quarterly) |
|---|---|
| Mar 2024 | $201 M |
| Jun 2024 | $198 M |
| Sep 2024 | $194 M |
| Dec 2024 | $216 M |
| Mar 2025 | $187 M |
| Apr 2025 | $187 M |
| Jun 2025 | $180 M |
| Sep 2025 | $176 M |
| Dec 2025 | $201 M |
| Mar 2026 | $170 M |
| Apr 2026 | $170 M |
| Jun 2026 | $166 M |
Debt-to-equity
- Debt-to-equity 0.09×
| Quarter | Debt-to-equity |
|---|---|
| Mar 2024 | 0.09× |
| Jun 2024 | 0.09× |
| Sep 2024 | 0.09× |
| Dec 2024 | 0.10× |
| Mar 2025 | 0.09× |
| Apr 2025 | 0.09× |
| Jun 2025 | 0.09× |
| Sep 2025 | 0.08× |
| Dec 2025 | 0.09× |
| Mar 2026 | 0.09× |
| Apr 2026 | 0.09× |
| Jun 2026 | 0.09× |
What is the Exelixis shareholding pattern?
13.0% of Exelixis, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so a large group of traders is betting against it. At normal trading volumes, closing those positions would take about 11.7 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead.
There is no quarter-by-quarter list of owners here, so we look at short interest: the share of tradable shares held in short positions, which gain if the price falls.
It is a single reading at one point in time; we do not have its history.
Why it is at this level: the figure does not say who has the short positions or why, so we show the level without guessing the story.
How far is Exelixis from balance-sheet trouble?
For Exelixis, Inc., the Z-score is 13.36. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure.
The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.
Why it matters: a Z-score of 13.36 is well clear of the danger zone, so the balance sheet is not the risk here.
How does Exelixis rank in its industry?
76.0 out of 100, rank 1 of 30 in Biotechnology, with 81% of the evidence available.
Exelixis, Inc. scores 76.0 out of 100 against the 30 companies it is compared with in Biotechnology, ranking 1. Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks.
The four parts add up to the total exactly: 22.9 + 21 + 14.4 + 17.7 = 76. This is the same number shown on the industry page; it is worked out once for the whole group and read here.
What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.
Which companies is Exelixis compared with?
Exelixis ranks 1 of 30 Biotechnology companies on the 4-Factor Sector Score, with 76.0 out of 100.
- 1Exelixis, Inc. this pageEXEL · breaking out · Most evidence points up · 81% evidence76.0out of 100
How the score adds up
Growth & earnings 22.9/35 · Revenue 9.3% · Profit 42.8% · Operating margin change 1.9 points · 83% evidenceCapital efficiency 21.0/25 · ROCE 46.5% · Operating margin 39.5% · 76% evidenceValuation 14.4/20 · P/E 15.9× · PEG 0.3 · 65% evidenceRelative strength 17.7/20 · Lead over its industry 10.5% · Lead over S&P 500 37% · 1 year 78.3% · 100% evidence · 8 of 12 weeks aheadExact sum: 22.9 + 21 + 14.4 + 17.7 = 76 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. - 2Halozyme Therapeutics, Inc.HALO · leader · Most evidence points up · 81% evidence71.1out of 100
How the score adds up
Growth & earnings 17.1/35 · Revenue 41.1% · Profit -25.9% · Operating margin change -2.4 points · 83% evidenceCapital efficiency 21.0/25 · ROCE 42.3% · Operating margin 59.8% · 76% evidenceValuation 14.4/20 · P/E 22.4× · PEG 0.25 · 65% evidenceRelative strength 18.6/20 · Lead over its industry 22.6% · Lead over S&P 500 50.7% · 1 year 91% · 100% evidence · 12 of 12 weeks aheadExact sum: 17.1 + 21 + 14.4 + 18.6 = 71.1 · What this means: Relative strength against the index is 50.7%, and revenue and profit growth are weak. - 3Caris Life Sciences, Inc.CAI · leader · Most evidence points up · 64% evidence65.7out of 100
How the score adds up
Growth & earnings 23.7/35 · Revenue 85.4% · Profit — · Operating margin change 20.1 points · 62% evidenceCapital efficiency 13.1/25 · ROCE 14.8% · Operating margin 10.2% · 76% evidenceValuation 11.2/20 · P/E -14.2× · PEG — · 15% evidenceRelative strength 17.7/20 · Lead over its industry 10.2% · Lead over S&P 500 37.4% · 1 year 29.7% · 100% evidence · 12 of 12 weeks aheadExact sum: 23.7 + 13.1 + 11.2 + 17.7 = 65.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 4Incyte CorporationINCY · turning · Evidence leans up · 71% evidence64.3out of 100
How the score adds up
Growth & earnings 26.4/35 · Revenue 26.9% · Profit 85.3% · Operating margin change 16.3 points · 83% evidenceCapital efficiency 20.6/25 · ROCE 28.1% · Operating margin 41.9% · 76% evidenceValuation 10.7/20 · P/E 14× · PEG — · 15% evidenceRelative strength 6.6/20 · Lead over its industry -13.6% · Lead over S&P 500 7.7% · 1 year 15.9% · 100% evidence · 5 of 12 weeks aheadExact sum: 26.4 + 20.6 + 10.7 + 6.6 = 64.3 · What this means: Earnings are strong; relative strength in its sector is -13.6% and the one-year return is 15.9%. - 5Genmab A/SGMAB · leader · Evidence leans up · 81% evidence60.8out of 100
How the score adds up
Growth & earnings 10.7/35 · Revenue 18.2% · Profit -39.3% · Operating margin change -3.7 points · 83% evidenceCapital efficiency 15.7/25 · ROCE 11.7% · Operating margin 35.2% · 76% evidenceValuation 14.9/20 · P/E 21.4× · PEG 0.21 · 65% evidenceRelative strength 19.5/20 · Lead over its industry 32.8% · Lead over S&P 500 65.2% · 1 year 92.3% · 100% evidence · 12 of 12 weeks aheadExact sum: 10.7 + 15.7 + 14.9 + 19.5 = 60.8 · What this means: Relative strength against the index is 65.2%, and revenue and profit growth are weak. - 6argenx SEARGX · turning · Evidence leans up · 85% evidence58.8out of 100
How the score adds up
Growth & earnings 24.7/35 · Revenue 60.6% · Profit 22.4% · Operating margin change 5.9 points · 95% evidenceCapital efficiency 16.9/25 · ROCE 18.9% · Operating margin 36.3% · 76% evidenceValuation 9.8/20 · P/E 32× · PEG 1.39 · 65% evidenceRelative strength 7.4/20 · Lead over its industry -18.3% · Lead over S&P 500 2.3% · 1 year 9% · 100% evidence · 6 of 12 weeks aheadExact sum: 24.7 + 16.9 + 9.8 + 7.4 = 58.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 7Kymera Therapeutics, Inc.KYMR · turning · Evidence leans up · 61% evidence57.6out of 100
How the score adds up
Growth & earnings 23.7/35 · Revenue 100% · Profit — · Operating margin change 620.5 points · 62% evidenceCapital efficiency 6.8/25 · ROCE -22% · Operating margin -116.3% · 76% evidenceValuation 10.0/20 · P/E — · PEG — · 0% evidenceRelative strength 17.1/20 · Lead over its industry 12.3% · Lead over S&P 500 38.4% · 1 year 132.3% · 100% evidence · 7 of 12 weeks aheadExact sum: 23.7 + 6.8 + 10 + 17.1 = 57.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 8Vertex Pharmaceuticals IncorporatedVRTX · breaking out · Evidence leans up · 81% evidence56.1out of 100
How the score adds up
Growth & earnings 15.9/35 · Revenue 10.2% · Profit 21.1% · Operating margin change -0.8 points · 83% evidenceCapital efficiency 19.6/25 · ROCE 20.9% · Operating margin 38.1% · 76% evidenceValuation 10.9/20 · P/E 28.6× · PEG 1.25 · 65% evidenceRelative strength 9.7/20 · Lead over its industry -13% · Lead over S&P 500 8.5% · 1 year 34.1% · 100% evidence · 8 of 12 weeks aheadExact sum: 15.9 + 19.6 + 10.9 + 9.7 = 56.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 9Spyre Therapeutics, Inc.SYRE · quiet · Too little evidence to rank firmly · 56% evidence55.8out of 100
How the score adds up
Growth & earnings 23.3/35 · Revenue — · Profit — · Operating margin change 999.3 points · 52% evidenceCapital efficiency 8.6/25 · ROCE -24.5% · Operating margin — · 61% evidenceValuation 10.9/20 · P/E -8.2× · PEG — · 15% evidenceRelative strength 13.0/20 · Lead over its industry 18.5% · Lead over S&P 500 43.8% · 1 year 339.8% · 100% evidence · 4 of 12 weeks aheadExact sum: 23.3 + 8.6 + 10.9 + 13 = 55.8 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. - 10BeOne Medicines AGONC · leader · Evidence leans up · 64% evidence54.9out of 100
How the score adds up
Growth & earnings 22.3/35 · Revenue 34.3% · Profit — · Operating margin change 12.4 points · 62% evidenceCapital efficiency 13.4/25 · ROCE 13.1% · Operating margin 19.1% · 76% evidenceValuation 9.1/20 · P/E 48.3× · PEG — · 15% evidenceRelative strength 10.1/20 · Lead over its industry -13.3% · Lead over S&P 500 8.4% · 1 year 17.7% · 100% evidence · 12 of 12 weeks aheadExact sum: 22.3 + 13.4 + 9.1 + 10.1 = 54.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 11Moderna, Inc.MRNA · leader · Evidence leans up · 64% evidence54.7out of 100
- 12Jazz Pharmaceuticals plcJAZZ · quiet · Evidence leans up · 74% evidence53.6out of 100
- 13Regeneron Pharmaceuticals, Inc.REGN · leader · Evidence leans up · 81% evidence51.9out of 100
- 14Alnylam Pharmaceuticals, Inc.ALNY · quiet · Evidence leans up · 64% evidence51.1out of 100
- 15Royalty Pharma plcRPRX · turning · Evidence leans up · 81% evidence50.9out of 100
- 16ImmunityBio, Inc.IBRX · breaking out · Evidence leans down · 61% evidence49.5out of 100
- 17Protagonist Therapeutics, Inc.PTGX · losing its lead · Evidence leans down · 74% evidence49.2out of 100
- 18Bio-Techne CorporationTECH · turning · Evidence leans down · 74% evidence42.2out of 100
- 19Summit Therapeutics Inc.SMMT · breaking out · Too little evidence to rank firmly · 53% evidence39.7out of 100
- 20Revolution Medicines, Inc.RVMD · quiet · Too little evidence to rank firmly · 53% evidence39.5out of 100
- 21Roivant Sciences Ltd.ROIV · turning · Too little evidence to rank firmly · 60% evidence38.0out of 100
- 22Madrigal Pharmaceuticals, Inc.MDGL · quiet · Evidence leans down · 61% evidence36.4out of 100
- 23Insmed IncorporatedINSM · basing · Evidence leans down · 61% evidence35.2out of 100
- 24BridgeBio Pharma, Inc.BBIO · quiet · Most evidence points down · 61% evidence34.8out of 100
- 25BioNTech SEBNTX · quiet · Most evidence points down · 64% evidence32.4out of 100
- 26BioMarin Pharmaceutical Inc.BMRN · quiet · Most evidence points down · 81% evidence26.7out of 100
- 27Ascendis Pharma A/SASND · turning · Too little evidence to rank firmly · 44% evidence63.0out of 100
- 28Apogee Therapeutics, Inc.APGE · Too little evidence to rank firmly · 27% evidence46.7out of 100
- 29Nuvalent, Inc.NUVL · Too little evidence to rank firmly · 20% evidence40.9out of 100
- 30Vaxcyte, Inc.PCVX · breaking out · Too little evidence to rank firmly · 47% evidence38.2out of 100
Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.
The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.
Related companies: Biotechnology, all 30 compared on one page.
Which companies are close to Exelixis in size?
Exelixis is the 14th largest of 211 Biotechnology companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: Insmed Incorporated, BioNTech SE and Alnylam Pharmaceuticals, Inc. Just below it: Ascendis Pharma A/S, BridgeBio Pharma, Inc. and Jazz Pharmaceuticals plc.
Biotechnology companies close in size
- Insmed Incorporated $24.1 billion
- BioNTech SE $22.5 billion
- Alnylam Pharmaceuticals, Inc. $21.6 billion
- Exelixis, Inc. $17.8 billion
- Ascendis Pharma A/S $16.9 billion
- BridgeBio Pharma, Inc. $15.2 billion
- Jazz Pharmaceuticals plc $15.1 billion
All 211 Biotechnology companies, largest first
Companies close in size in other industries
- Hyatt Hotels Corporation $17.8 billion · Lodging
- YPF Sociedad Anónima $17.8 billion · Oil & Gas Integrated
- Exelixis, Inc. $17.8 billion
- Brookfield Infrastructure Partners L.P. $17.7 billion · Utilities - Diversified
- RB Global, Inc. $17.6 billion · Specialty Business Services
What else do people ask about Exelixis?
What were Exelixis's latest quarterly results?
Exelixis, Inc. reported revenue of $629 M and net profit of $212 M for the Jun 2026 quarter. Revenue rose 10.6% and profit rose 14.7% compared with a year earlier. Earnings per share were $0.82.
The operating margin was 39.5%, 1.9 percentage points higher than a year earlier (as of 4 November 2026).
What is Exelixis's market cap?
Exelixis, Inc.'s market capitalisation is $17.8 B at a stock price of $72.75. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026).
How is Exelixis performing?
Exelixis, Inc.'s share price has been rising for 32 weeks. In its latest quarter, revenue rose 10.6% and profit rose 14.7% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 12 weeks running (as of 4 November 2026).
Will Exelixis's stock price go up?
This page does not forecast Exelixis, Inc.'s stock price. What it shows instead: the stock price is $72.75, and it has been rising for 32 weeks. Its P/E of 21.7× is higher than 54% of its own last 5 years (as of 4 November 2026).
Where is Exelixis in its business cycle?
Exelixis, Inc.'s FY25 operating margin was 38.5%, against a 5-year range of 9.3% to 38.5%: the top of its range, a record year. When profit is at a record, every ratio looks better than usual, and the story depends on margins staying high. The latest quarter was 39.5%.
Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026).
What could break the Exelixis story?
Biggest thing to watch: margins are the best this company has ever reported. Every ratio looks better at a record, so the story depends on margins staying high.
On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026).
Is Exelixis a stock worth studying right now?
What the numbers show: Exelixis, Inc. is reporting record margins. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026).
Where do these numbers come from?
Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.
Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.
See the plain-text version of this page.
More lists
Every Sector Alpha list, grouped
Stock screens
Market lists
Themes
Sectors
US stocks
X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.